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Reproductive Genetic Testing: What America Thinks
We are currently in the midst of a genetic revolution in medicine. Advances in 
science, especially the completion of the human genome sequence, have led to greater 
understanding of the role of genes in health and disease. Genetic tests for diseases and 
disease risks are available currently and new medicines and preventive strategies are on 
the horizon. 
Many people fi rst encounter genetic testing when having a baby. Reproductive genetic 
testing — carrier testing, prenatal genetic testing, preimplantation genetic diagnosis 
— combines the newest advances in genetics with the most profound human activity of 
creating life.  Reproductive genetic testing provides information: information about the 
risk of parents passing a genetic mutation to their children; information about the genetic 
characteristics of embryos produced through in vitro fertilization; information about 
the genome of a fetus in utero.  Th is information can provide reassurance to prospective 
parents, or the basis for important decisions: to attempt a pregnancy or not; to transfer an 
embryo to the uterus or not; to continue a pregnancy or not.  Th e growing availability and 
use of reproductive genetic testing presents a host of complicated ethical, legal and social 
issues.  
New genetic technologies will touch the lives of millions of Americans. Yet, there 
is relatively little oversight of reproductive genetic testing.  As the number and type 
of genetic tests grows and their use becomes more widespread, the time has come to 
seriously consider whether and how these new technologies will aff ect individuals and 
shape society, and whether changes in oversight are needed.  Some believe that the 
decision to use reproductive genetic testing should be left  up to individual parents in 
consultation with their doctors. Others believe that reproductive genetic tests should be 
either controlled stringently or banned entirely. 
Th e growing debate about the use and oversight of reproductive genetic testing has 
been largely framed by two opposing views: those who see reproductive genetic testing as 
an opportunity to prevent suff ering and who oppose limitations on research, technological 
advance and reproductive choice; and those who believe that reproductive genetic 
testing will have adverse ethical and social impacts and who support restrictions on its 
development and use. Th e views of most Americans, however, are more nuanced and 
elastic, refl ecting the tensions among hopes, values and personal experience.
Th e Center has undertaken an in-depth eff ort to assess public attitudes toward genetic 
technologies — with public opinion surveys, town hall meetings, focus groups, interviews 
and online group discussions — as a means of making the discussion about genetics and 
public policy more democratic, less divisive and less the province of special interests. 
Th e goal is not to encourage policy making by public referendum, but to give everyone 
involved a clearer sense of the diversity of opinion surrounding these issues.
From 2002 to 2004 we used multiple methods to conduct a comprehensive assessment 
of Americans’ opinions about reproductive genetic testing and technologies. Th is 
assessment included two surveys — one of which is the largest to date on this topic 
— focus groups and interviews.  We organized public meetings around the country and 
invited those whose voices are not typically heard by policy makers; we held meetings 
with stakeholders to gather their input on policy options; and we held interactive forums 
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online that allowed individuals to register their opinions. Th is report, Reproductive Genetic 
Testing: What America Th inks, presents the results of our research on the public’s attitudes 
about reproductive genetic testing and possible approaches to its oversight.
Th e accompanying report, Reproductive Genetic Testing: Issues and Options for 
Policymakers, aims to help focus and facilitate the discussion about reproductive genetic 
testing by outlining key scientifi c and medical facts, considering ethical and social 
implications, and assessing both current and potential oversight for the development and 
use of reproductive genetic tests. It presents a range of policy options supported by expert 
analysis that consider the potential eff ects, positive and negative, of distinctly diff erent 
policy directions. Our goal at the Genetics and Public Policy Center is not to advocate 
for or against any technology or policy outcome but to make sure that policy decisions, 
including the decision to maintain the status quo, are undertaken with a clear-eyed 
understanding of their potential impact. 
We hope that together these two reports will be useful tools for enhancing public 
discussion of reproductive technologies and assisting decision makers in both the 
private and public sectors as they consider policies to govern the development and use of 
reproductive genetic testing.
Kathy Hudson
Director, Genetics & Public Policy Center
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Why Conduct Public Opinion 
Research?
Th e Genetics and Public 
Policy Center operates under the 
principle that, in a democratic 
system of government, the voice 
of the public is critical in making 
sound public policy decisions.  To 
better understand the views of the 
public about reproductive genetic 
testing, the Center conducted 
both qualitative and quantitative 
research between October 2002 
and August 2004.  Findings from 
this research are being used to 
support the Center’s goals of 
providing appropriate informational 
materials for policymakers, the 
public and the media; developing a 
comprehensive set of policy options; 
and engaging key stakeholders and 
decision makers in both the private 
and public sectors.  Th is report 
summarizes the fi ndings from our 
research into public opinions about 
reproductive genetic testing.
Who Was Consulted?
Th e Center has engaged in a series 
of research projects designed to elicit 
public opinion about the use and 
regulation of reproductive genetic 
testing.  It began with a telephone 
survey of 1,211 members of the 
general public in 2002.2   
To get a nuanced picture of 
the public’s level of knowledge 
and opinions about reproductive 
genetic testing, 21 focus groups 
were conducted in fi ve cities 
with members of the general 
public — most of whom had little 
experience with reproductive genetic 
testing.  To ensure that a broad 
range of perspectives were solicited, 
participants were grouped by gender, 
age, race/ethnicity, parental status 
and education (see Appendix).  In 
order to obtain the full range of 
views and perspectives related to the 
technologies, telephone interviews 
were conducted with 62 people who 
had experience with reproductive 
genetic testing, including adults with 
a genetic disease, parents of children 
with a genetic disease, individuals 
with personal experience using 
preimplantation genetic diagnosis 
and health-care providers (Table 
1.1). 
In 2004, the Center conducted 
a nationally representative survey 
of 4,834 people via the Internet in 
order to test hypotheses and explore 
issues that emerged from the focus 
groups in a representative sample of 
the general public.  Th is is the largest 
survey of American opinions on this 
topic to date.  
One of the criticisms of both 
quantitative and qualitative opinion 
research, especially in the area of 
science policy, is that individuals 
are asked to comment on issues 
involving complex technologies 
about which they may have had little 
opportunity to consider in depth. 
Chapter 1: Introduction
Table 1.1:  Summary of Public Opinion Research Studies
Study Methodology Data Collection 
Period
Number of Participants Description of Population(s)
Telephone survey October 2002 1,211 Nationally representative sample 
Internet survey April 2004 4,834 Nationally representative sample 
Focus groups April 2003 21 focus groups with 
181 total participants





62 total Parents of children with genetic disease (5)
Adults with genetic disease (5)
Individuals who have experience with PGD (13)
Primary care providers (20)
PGD health-care providers (19)
In-person town halls June 2004-
August 2004
536 Members of the general public in six U.S. cities 
Online town halls July 2004-
August 2004
133 Members of the general public
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What Is Reproductive Genetic Testing?
Genetic testing is the laboratory analysis of DNA, RNA or chromosomes.  Testing can also involve analysis of proteins 
or metabolites that are the products of genes. Genetic testing is done to predict risk of disease, screen newborns for 
disease, identify carriers of genetic disease, establish prenatal or clinical diagnoses or prognoses and direct clinical 
care.  Testing can be done using many diff erent biological samples, including blood, amniotic fl uid (from which fetal 
cells are obtained) or individual embryonic cells.
Reproductive genetic testing refers to those genetic tests and procedures that are used to provide prospective parents 
with information about their chances of having a child with a specifi c genetic disorder or characteristic in a current or 
future pregnancy.  It includes: (1) carrier testing, which is done to determine whether an individual carries one copy of 
an altered gene for a particular recessive condition; (2) prenatal genetic testing, in which fetal cells obtained through 
procedures such as amniocentesis and chorionic villus sampling (CVS) are genetically tested; and (3) preimplantation 
genetic diagnosis (PGD), in which embryos produced through in vitro fertilization are genetically tested to select 
which embryos to transfer to a woman’s uterus.
Carrier testing is genetic testing to determine whether an individual carries one copy of an altered gene for a 
particular recessive condition. Carrier testing is done because of a family history of a genetic disorder or because of 
racial or ethnic background.  Examples of autosomal recessive disorders that are more frequent in certain populations 
for which carrier testing can be done include cystic fi brosis in Whites, sickle cell disease in Blacks, thalassemia in 
Asians and individuals of Mediterranean descent, and Tay Sachs disease, Canavan disease and familial dysautonomia 
in Ashkenazi Jews.  In autosomal recessive disorders, a person must have two copies of the mutation to be aff ected.  
Individuals who carry one copy of the alteration are carriers and typically show no signs of the disease. When both 
parents are carriers, there is a one in four, or 25 percent, risk for each child to inherit the mutation from both parents 
and be aff ected. 
Preimplantation genetic diagnosis (PGD) is genetic testing that is done on embryos produced through in vitro 
fertilization.  Most commonly, one or two cells are removed from the embryo and tested for the presence of a 
particular trait or condition.  Th e test results are used to inform the selection of embryos for transfer to a woman’s 
uterus.  For example, parents may want to select only embryos that do not have a particular genetic mutation or that 
have a particular genetic characteristic, such as sex.  Preimplantation genetic diagnosis has been used for patients 
carrying chromosomal rearrangements and those at risk of transmitting a single gene disorder to their off spring.  
It has also been used to detect chromosomal abnormalities in embryos from women of advanced maternal age 
undergoing fertility treatment.  
Prenatal genetic testing (or prenatal genetic diagnosis) is genetic testing of fetal cells obtained through procedures 
such as amniocentesis and chorionic villus sampling (CVS).  Test results may be used to help parents prepare for the 
birth of an aff ected child or make a decision about terminating the pregnancy. 
Prenatal screening involves those tests and procedures used to assess fetal risk for an abnormality, including genetic 
disorders.  It does not provide a defi nitive diagnosis of a genetic abnormality.
In Vitro Fertilization (IVF) is a process in which eggs are retrieved from a woman’s ovaries and fertilized with 
sperm in the laboratory, and the resulting embryos are grown in culture and then transferred into a woman’s uterus.  
Embryos that are not transferred may be discarded, frozen and stored for future use, donated to other couples or used 
for research.
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Introduction
Th us, the Center undertook a project 
to assess whether people would 
have more informed, refl ective 
opinions if they had a chance to 
learn more about the technology and 
issues, hear contrasting viewpoints 
from “the experts” and engage in 
discussion with their fellow citizens 
about the issues. 
To capture opinion data based 
on informed decisions, an extensive 
public engagement activity took 
place during the summer of 2004 
called Th e Genetic Town Hall: 
Making Every Voice Count.  Th e 
engagements took place in six U.S. 
cities using a town hall format and 
with 15 discussion groups online 
using state-of-the-art Internet 
meeting capability.  A separate 
report, Th e Genetic Town Hall: 
Making Every Voice Count, which 
summarizes the fi ndings from this 
project, will be available through the 
Center.
A description of the 
methodologies for each study is 
provided in the Appendix.
NOTES:
1 Public Awareness and Attitudes about 
Reproductive Genetic Technology, available at 
www.DNApolicy.org
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Figure 2.1 Awareness of Genetic Technologies
“Before today, had you ever heard about ...”
Source: 2004 Survey
Chapter 2: Public Awareness and Knowledge  
Prior to asking any questions 
about people’s opinions concerning 
reproductive genetic testing, it was 
important to get a sense of how 
aware Americans were about these 
technologies, and how much they 
really understood about genetics and 
the current capabilities of genetic 
testing.
Focus group participants 
were presented with a series of 
hypothetical scenarios involving the 
use of diff erent reproductive genetic 
testing.  Th ey were then asked 
whether they had ever heard of a 
particular technology before and, 
if so, whether they could describe 
it.  Similarly, survey participants 
were provided with a defi nition of 
the technology and asked a series of 
awareness and knowledge questions.  
Many of these same questions were 
put to town hall participants prior to 
the discussions.  
Awareness
Th e majority of the focus 
group participants had heard of 
prenatal genetic testing, primarily 
amniocentesis for Down syndrome.  
Most had not heard of carrier testing, 
with the exception of participants 
in the Jewish women’s focus group, 
most of whom were highly educated 
and had children.  Several of these 
women reported that they had had 
carrier testing for Tay Sachs disease, 
which is more prevalent among 
Ashkenazi Jews.  Preimplantation 
genetic diagnosis (PGD) was 
unfamiliar to almost all focus group 
participants; however, a number of 
participants spontaneously predicted 
or envisioned a technology like PGD. 
Most of the interview participants 
who had used or considered PGD 
reported that they fi rst became aware 
of the technology only aft er the birth 
of an aff ected child. Information 
typically came from a genetic 
counselor rather than a primary 
care provider, the media or a genetic 
disease support group. Participants 
reported that they had diffi  culty 
locating both unbiased information 
about PGD and PGD providers.
Based on survey data, a majority 
of the American public was aware 
of technologies that have been in 
clinical use for a longer period of 
time, such as in vitro fertilization 
(IVF) and prenatal genetic testing, 
and with reproductive genetic 
technologies, like cloning, that have 
received extensive media attention, 
while only 40 percent said they had 
heard of PGD — a much newer 
technology (Figure 2.1).  
Awareness of reproductive 
genetic technologies varies not only 
by type of technology but also by 
socio-demographic characteristics 
(Table 2.1).  Aft er adjusting the 
results to account for diff erences 
in the demographic characteristics 
of respondents, the two most 
signifi cant characteristics associated 
with awareness of reproductive 
genetic testing technologies were 
being female and having a higher 
education. Lower income was 
associated with reduced likelihood 
of awareness of IVF and prenatal 
genetic testing.  Th ose who 
reported their political affi  liation as 
“other” were less aware of all of the 
technologies compared to people 
who self-identifi ed as Republican 
or Democrat.  Th ere were no 
statistically signifi cant diff erences in 
awareness between Republicans and 
Democrats.  
Knowledge
Focus group participants 
generally understood that 
genetic testing can be used to 
make reproductive decisions; 
however, there were some notable 
misperceptions about carrier testing 
and, to a lesser extent, about prenatal 
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Table 2.1: Proportion of Respondents Who Stated They Had Heard about the Following Technologies 
Prior to the Interview







Total 90.4 88.5 83.4 40.2 48.1 96.6
Sex Men 88.4 86.0 78.0 36.3 51.6 96.3
Women 92.3 90.9 88.3 43.9 44.9 96.9
Age 18-29 89.4 89.6 81.4 41.5 56.4 96.8
30-49 90.1 88.7 84.0 39.4 48.3 96.6
50+ 91.2 87.8 83.8 40.4 43.1 96.6
Race/
Ethnicity
White 92.8 91.0 85.1 41.4 50.4 97.7
Black 83.7 85.0 76.9 34.7 34.8 96.1
Hispanic 86.2 81.6 81.8 38.7 46.0 93.5
Religion Protestant* 91.3 90.3 83.3 41.0 42.6 98.3
Fund/Evang** 92.0 90.1 84.9 39.4 47.8 98.0
Catholic 92.7 88.9 84.8 39.5 50.8 96.8
Other Christian*** 88.6 87.9 86.0 42.7 45.1 96.0
Other (Non Christian) 88.3 82.3 76.5 30.7 55.6 93.3
No Religion 87.0 87.0 81.2 43.0 56.1 93.9
Income Under 25k 87.0 83.2 80.1 40.5 42.7 93.9
25k-49k 90.0 89.4 82.3 38.4 46.3 97.4
50k-74.9k 92.7 92.0 84.4 39.8 52.4 98.7
75+k 95.8 94.2 91.4 44.2 58.9 98.4
Education No College 85.6 82.5 77.4 34.2 35.5 94.6
Some College 92.0 92.0 84.8 43.6 53.2 98.0
College 97.7 96.5 93.8 45.0 65.3 99.2
Post Grad 97.8 96.2 92.2 53.1 68.8 98.4
Political
Affi liation
Republicans 92.5 91.2 86.8 38.9 48.9 98.4
Other 83.9 80.6 75.9 36.1 39.3 92.7
Democrats 89.8 86.6 81.4 38.2 45.3 96.6
Source: 2004 Survey
* Protestant includes respondents who self-identifi ed as Protestant, excluding those who additionally self-identifi ed as Fundamentalist or Evangelical.
** Fundamentalist/Evangelical includes all Protestant or Other Christian respondents who additionally self-identifi ed as either Fundamentalist or Evangelical.
*** Other Christian includes all who self-identifi ed as Other Christian, excluding those that additionally self-identifi ed as Fundamentalist or Evangelical.
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Awareness and Knowledge
testing.  A common misperception 
that arose in one-third of the 21 focus 
groups was the belief that carrier 
testing is unnecessary unless there 
is some family history of genetic 
disease. Other misperceptions about 
carrier testing included the belief 
that carrier testing is a routine part of 
prenatal care and, therefore, patients 
do not have a choice; the belief 
that carrier testing is the same as 
Rhesus (Rh) factor testing; the belief 
that carrier testing is diagnosing a 
condition in the fetus rather than 
providing information about the 
individual tested and the risk for a 
current or future pregnancy; and 
belief that carrier testing is a routine 
part of premarital blood testing.  
Misperceptions about prenatal testing 
included the belief that amniocentesis 
can provide information about all 
diseases and confusion about whether 
amniocentesis is a fetal biopsy or test 
of fetal blood, even among those who 
had experienced amniocentesis.  
Survey respondents were asked 
whether genetic testing can be used to 
fi nd out if a person has an increased 
risk of developing certain kinds of 
cancer or to fi nd out if a person has 
desirable characteristics such as high 
intelligence or strength.  Fift y-seven 
percent of the respondents correctly 
answered that genetic testing can 
detect an increased risk of contracting 
certain kinds of cancer, though a 
substantial minority (37 percent) 
did not know the answer.  More 
Americans (26 percent) answered 
incorrectly that genetic testing can 
detect traits such as intelligence than 
answered correctly that it cannot 
(22 percent) and a majority of those 
questioned stated they did not know 
(Figure 2.2).   
Higher education is clearly 
associated with a greater 
understanding of the capabilities of 
genetic testing (Table 2.2).  Sixty-
eight percent of those with post-
graduate education answered the 
cancer question correctly, while only 
50 percent of those with no college 
education answered correctly.  Even 
aft er adjusting for demographic 
characteristics such as income and 
race, diff erences by education remain 
robust. 
Fift y-eight percent of Whites 
correctly answered the question on 
cancer detection, compared to 51 
percent for Blacks and 55 percent 
for Hispanics. Aft er adjusting for 
demographic characteristics in 
logistic regression models, Blacks 
were still less likely than Whites 
to answer correctly, although the 
diff erences for Hispanics fell away.   
Fewer women answered knowledge 
questions correctly than men; these 
sex diff erences were still observed 
even aft er adjusting for demographic 
characteristics.  Diff erences among 
age groups were more pronounced 
in the knowledge question about 
desirable characteristics: older adults 
were less likely than younger age 
groups to answer correctly, even aft er 
controlling for other characteristics.  
Th e diff erences in knowledge 
among the religious groupings were 
relatively small, although as Table 
2.2 illustrates, the greatest number of 
correct answers were observed among 
respondents who either self-identifi ed 
as Other (Non Christian) or had no 
religious affi  liation.  
Figure 2.2 Knowledge of Genetic Technologies 
“As far as you know is it scientifi cally possible to use genetic testing to fi nd out if 








0% 20% 40% 60% 80% 100%
desirable characteristics
such as high intelligence
or strength?
a greater than average
chance of developing
certain kinds of cancer?
correct answer don't know wrong answer
10 Reproductive Genetic Testing: What America Thinks
Table 2.2: Percentage of Correct Responses to Genetic Testing 
Questions
Demographic Characteristics It is possible to 
test for certain 
kinds of cancer
It is not possible to 
test for intelligence 
or strength
Total 56.9 22.1
Sex Men 59.1 24.4
Women 54.9 20.0








Religion Protestant* 57.2 18.7
Fund/Evang** 55.2 19.0
Catholic 58.1 22.8
Other Christian*** 53.9 20.5
Other (Non Christian) 58.9 33.0
No Religion 60.6 29.7




Education No College 49.5 16.9
Some College 62.2 23.1
College 63.3 28.5







* Protestant includes respondents who self-identifi ed as Protestant, excluding those who additionally self-identifi ed as Fundamentalist or Evangelical.
** Fundamentalist/Evangelical includes all Protestant or Other Christian respondents who additionally self-identifi ed as either Fundamentalist or Evangelical.
*** Other Christian includes all who self-identifi ed as Other Christian, excluding those that additionally self-identifi ed as Fundamentalist or Evangelical.
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Reproductive genetic testing was 
developed to provide prospective 
parents with information about their 
risk of having a child with a severe, 
life-threatening genetic disease, but 
it is also possible to use it to identify 
other genetic characteristics of 
fetuses or embryos such as sex and 
tissue type.1 Researchers are learning 
more about genes responsible for 
a host of inherited characteristics 
— from disease risk to physical 
appearance — giving rise to new 
genetic tests that could be used to 
test embryos and fetuses.  In the 
future, it may be possible to test for 
genes that infl uence behavior or 
appearance.  
Preimplantation genetic diagnosis 
(PGD) can be used to identify and 
select embryos based on the absence 
of deleterious characteristics or 
the presence of desirable genetic 
characteristics.  Prenatal genetic 
testing can identify genetic 
characteristics of a fetus in utero.  
Test results can be used to provide 
reassurance, aid in preparing for 
the birth of an aff ected child or be 
the basis of the decision to continue 
or terminate the pregnancy.  For 
many Americans, the type of test 
and the motivations behind parents’ 
use of reproductive genetic testing 
are important considerations in 
assessing whether or not testing is 
appropriate.
To understand more about 
Americans’ opinions about the 
appropriate uses of reproductive 
genetic testing and what shapes 
them, survey, focus group, interview 
and town hall participants were 
asked their views about using 
reproductive genetic testing for 
diff erent purposes.  
Survey respondents were 
asked a set of questions about the 
appropriateness of using prenatal 
testing to fi nd out whether a fetus 
would:
•  develop a fatal childhood disease; 
•  have a tendency to develop a 
disease like adult-onset cancer; 
•  be a certain sex; 
•  be a good match to donate his or 
her blood or tissue to a brother 
or sister who is sick and needs a 
transplant; and 
•  have desirable characteristics 
like high intelligence or strength 
(hypothetically).  
Respondents were then asked 
whether it was appropriate to use 
PGD to select which embryo(s) to 
transfer to a woman’s uterus. 
Similarly, focus group and 
town hall participants were asked 
to discuss whether they thought 
prenatal genetic testing or PGD 
was appropriate for a range of 
circumstances.  
Use to Avoid Disease Not to 
Select for Desirable Traits
“I say yes if  it all leads to 
eradicating horrifying diseases, and 
not wanting to pick their perfect 
little baby-whether it be a boy or a 
girl, blonde and blue-eyed.”
participant from female focus 
group, California
Americans’ support for the use of 
reproductive genetic testing depends 
heavily on the circumstances for 
which it is being used.  In the 2004 
survey, about two-thirds of the 
general public approved of the 
use of prenatal genetic testing and 
PGD for a fatal childhood disease 
and for tissue matching (Figure 





















Chapter 3: Perceptions About Appropriate Uses 
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3.1).  A majority of both survey and 
town hall participants approved of 
using reproductive genetic testing 
technologies to identify alterations 
associated with a tendency to 
develop an adult-onset disease like 
cancer.  Th ere was less support for 
testing to identify, if it were possible, 
characteristics like intelligence 
or strength.  Th erefore a majority 
of Americans think that testing 
for health-related purposes is an 
appropriate use of reproductive 
genetic testing, but only a minority 
support its use for trait selection.  
While there is much less support 
for reproductive genetic testing 
for non-health-related purposes, 
these levels were not as low as one 
might expect.  Indeed, greater than 
one in four Americans said they 
approved or strongly approved of 
using hypothetical genetic tests for 
intelligence or strength.  Since the 
survey question asked whether it is 
appropriate to use prenatal genetic 
testing to identify sex rather than 
to make a decision about abortion 
based on this information, perhaps 
it is not surprising that about half 
of those surveyed supported this 
use.  In fact, during routine prenatal 
ultrasound, the sex of a fetus is oft en 
identifi ed and this information 
shared with the parents.  Close to 
40 percent of Americans think that 
using PGD solely to select for sex is 
an appropriate use of the technology. 
A signifi cant minority — almost 
one-third — of Americans 
disapproved of testing for fatal 
childhood disease or a tissue match 
for a sick sibling. 
Prevent the Suffering of a Child
“I have the [sickle cell] trait, and 
a couple of  my cousins have it… 
I have seen a lot of  pain and 
suffering from sickle cell…and it 
wasn’t pretty.”
participant from Black female 
focus group, Michigan
Focus group and town hall 
discussions shed light on why 
there is strong support for using 
reproductive genetic testing to 
identify severe, childhood genetic 
disease.  Participants who believe 
that this use is morally appropriate 
typically stated that preventing the 
suff ering of a child is a laudable goal.  
Th ey described genetic disease as 
a substantial burden for children, 
families and communities.  
“[Sickle cell] is killing us wholesale 
through our community. So, if  you 
actually have an opportunity where 
we can utilize a little bit of  modern 
technology and science to where, 
let’s get rid of  this cancer in our 
community, why not?”
participant from Black male focus 
group, Tennessee
“Cystic fi brosis is nasty and it is 
horrible and it is debilitating and 
painful and causes suffering.”
participant from female White 
focus group, California
Some of the parents of aff ected 
children said that others could not 
possibly understand how diffi  cult 
it is to care for and watch helplessly 
while a child suff ers.  Th e emotional 
and fi nancial burden of raising a 
disabled or sick child, the burden on 
siblings, the eff ect on the stability of
the parents’ marriage, potential 
parental guilt at having given a child 
a genetic disease and concerns about 
loss of family health insurance were 
all cited as reasons reproductive 
genetic testing is a valid option. 
In fact, some parents of aff ected 
children and some adults with 
genetic diseases said they were 
determined not to bring another 
person into the world with the same 
condition.  
“There’s water gushing in your boat, 
you’re sinking, you have a bucket.  
And you just keep taking the bucket 
and you throw water on it to keep 
from sinking, and there’s no break.  
It’s seven days a week, 24 hours 
a day.  You don’t get a vacation.  
That’s it.  You are stuck on this boat 
in the middle of  the ocean with a 
hole in it with a bucket.  And that’s 
what life is like raising a boy with 
CF.”
father of  child with cystic fi brosis 
(interview)
Not all shared this view. Others 
had a very diff erent perspective on 
the challenges they or their family 
faced. Among this group, there was 
little interest in technologies that 
could prevent the birth of an aff ected 
child.   
When asked to identify the most 
important benefi t to parents of being 
able to select characteristics of their 
children, town hall participants 
across the country placed the ability 
to avoid having a child with genetic 
disease, to have healthier children 
or to prevent the suff ering of a child 
at or near the top of their list.  Some 
also stressed the need to reduce the 
suff ering of the entire family.  
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Some interview participants, 
particularly health-care providers, 
said reproductive genetic testing also 
has the potential to benefi t society 
by reducing the burden of disease 
and the costs of treatment for future 
generations.  One provider noted 
that carrier and prenatal genetic 
testing have already reduced the 
number of babies born with Tay 
Sachs disease, and that PGD has the 
potential to do the same for other 
genetic diseases.  
“I am hoping that, like vaccination, 
PGD will eliminate some of  these 
ravaging diseases from occurrence.”
PGD provider (interview)
During many of the focus group 
and town hall discussions, it became 
clear that some participants believe 
there may be a moral obligation 
to use reproductive genetic testing 
if the purpose is to prevent the 
suff ering of a child.  
“You have a responsibility to bring 
a child into the world with a certain 
quality of  life.”
female participant from mixed sex/
race focus group, Massachusetts
Th e theme that there may be a 
moral obligation to use reproductive 
genetic technology to prevent 
suff ering was explored in the 
survey.  Aft er answering over 80 
questions about reproductive genetic 
technologies, survey participants 
were asked whether they strongly 
agreed, agreed, disagreed or strongly 
disagreed with the following 
statement: “Parents ought to do 
everything technologically possible 
to prevent their child from suff ering 
including using reproductive genetic 
technologies.”  Responses were 
evenly split (Table 3.1). 
Pronounced diff erences in 
opinion over whether or not 
parents have an obligation to use 
reproductive genetic technologies to 
prevent suff ering in their children 
were observed between religion 
groups (Table 3.2).  Notably, 
far fewer Fundamentalist and 
Evangelical Christians agreed 
with this statement compared to 
other Protestants.  For other socio-
demographic characteristics, more 
women, more Democrats and 
a greater number of Blacks and 
Hispanics agreed that parents had 
such an obligation.
 
Th ere is strong support for using 
these technologies when there is 
a health benefi t, even when that 
benefi t is for another person.  One 
of the uses of reproductive genetic 
testing is to determine whether an 
embryo or a fetus is a good tissue 
match and could potentially provide 
life-saving cells to a critically ill 
sibling.  In the 2004 survey, 72 
percent of respondents either 
approved or strongly approved of 
the use of prenatal genetic testing 
“to fi nd out whether a baby will be 
a good match to donate his or her 
blood or tissue to a brother or sister 
who is sick and needs a transplant.” 
Sixty-six percent supported the use 
of PGD for this purpose (Figure 3.1). 
Data from the town halls are similar.  
Th is use was discussed during many 
of the interviews and one of the 
focus groups.  Th ese qualitative data 
also demonstrate strong support 
for using PGD to select an embryo 
that will result in a baby whose cells, 
usually umbilical cord stem cells, 
can help save a sick or dying older 
sibling.
“I don’t think anyone wants to see 
their child die… you’d do anything 
to save the child’s life.”
male participant from mixed sex 
focus group, Massachusetts
“I think that there’s a lot worse 
things than having a child to save 
another child.”
mother of  child with genetic 
disease (interview)
Preparing For a Special Needs 
Child   
“The information is… just a 
powerful thing to have.”
participant from young male focus 
group, Tennessee
Prenatal genetic testing is 
available to pregnant women to 
identify fetuses aff ected by some 
genetic diseases.  Th is information 
can be used to make a decision 
about whether or not to continue 
the pregnancy.  Some women who 
would never consider abortion or 
who are concerned about the risk 
of miscarriage may refuse testing.  
Others, even though they would not 
consider abortion, nevertheless may 
choose to test simply to have more 
information about the pregnancy.  
Most focus group participants 
thought that prenatal genetic testing 
should be available and off ered to 
pregnant women and that it is then 
up to women, and their partners, 
to decide whether to have genetic 
testing and what to do with the 
information it provides.
Appropriate Uses
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While many participants in the 
focus groups said that prenatal 
testing creates anxiety, others said 
that having additional information 
about the fetus is a benefi t of 
prenatal genetic testing.  Negative 
test results can provide “peace of 
mind” by letting the couple know 
for sure that the child will not have a 
particular genetic disease.
“[We did it] because I wanted to 
kind of  relieve the stress of  the 
pregnancy, because wondering all 
the time, and waiting to fi nd out 
if  the baby’s going to be healthy 
or not, it was very stressful… once 
we got the results, then we could 
kind of  smoothly sail through the 
pregnancy.”
woman with genetic disease 
(interview) 
When town hall participants were 
asked to name and then rank the 
most important benefi ts to parents 
of being able to identify the genetic 
characteristics of their children, the 
ability to plan and prepare for the 
challenges of having a special needs 
child was always mentioned and 
ranked at or near the top.  Focus 
group and interview participants also 
mentioned that prenatal testing gives 
parents time to prepare emotionally, 
fi nancially and medically for the 
birth of a special needs child.  
Table 3.1: Parents Ought to do Everything Technologically Possible 
to Prevent Their Child from Suffering Including Using Reproduc-
tive Genetic Technologies. 














Other (Non Christian) 56.6
No religion 58.5














* Protestant includes respondents who self-identifi ed as Protestant, excluding those who additionally self-identifi ed as Fundamentalist or Evangelical.
** Fundamentalist/Evangelical includes all Protestant or Other Christian respondents who additionally self-identifi ed as either Fundamentalist or Evangelical.
*** Other Christian includes all who self-identifi ed as Other Christian, excluding those that additionally self-identifi ed as Fundamentalist or Evangelical.
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“I think for us, not only just in 
terms of  the intellectual piece 
of  learning about the disease in 
advance and how to cope with 
it, but the actual grief  process of  
feeling the loss of  a healthy child 
— I think it was valuable to go 
through part of  that, even while 
pregnant, so that by the time the 
baby was born, some of  that was 
over. Because I think that could 
be brutal.  If  you had postpartum 
depression, [you might be] 
completely overwhelmed by all this 
information.”
mother of  child with genetic 
disease (interview)
Preparations might include 
learning more about the disease, 
identifying health-care specialists, 
making sure health insurance will 
cover the child’s medical costs, 
moving to a location with the best 
climate and medical care for that 
disease, rearranging employment 
and/or working hours, and 
mobilizing their support system of 
friends and family.
“…I would want to know if  [the 
baby] had cystic fi brosis, if  that 
test was positive, because then I 
would be fi nding everything in the 
world out that I could about cystic 
fi brosis, and preparing to give 
that baby the best, even if  it is fi ve 
months, the best life that that baby 
could have…”
participant from female 
Evangelical focus group, Colorado
Avoiding Non-fatal, Adult-onset 
Diseases
“[Y]ou have to start looking at 
which [diseases] are you going to 
fi x… cystic fi brosis, and the colon 
cancer, and the depression…Where 
do you stop?”
female participant from mixed 
sex/race focus group of  people 
over 55,California 
Survey participants were asked 
about the appropriateness of using 
reproductive genetic testing to avoid 
adult-onset diseases like cancer.  
Similarly, focus group participants 
were asked to consider use for 
adult-onset disease like cancer, 
obesity and depression.  Focus group 
participants oft en considered the 
severity of the disease, disability, 
or condition.  If the disease is fatal 
and has an early onset, respondents 
were more likely to view using 
the technology as appropriate.  In 
contrast, there was less approval for 
testing for adult-onset diseases, risk 
of disease, diseases infl uenced by 
behavior or the environment, and 
those for which a treatment exists.
Among survey respondents, 60 
percent approved of using prenatal 
testing to identify fetuses at risk of 
adult-onset disease, and 58 percent 
approved of using PGD to avoid 
transferring embryos that have 
an increased risk of developing 
an adult-onset disease (Figure 
3.1).  Th e split between those who 
approved and disapproved of this 
use was evident in the focus group 
discussions; in fact, individual 
participants frequently were 
ambivalent about this use.  Of those 
focus group and town hall 
participants who did not support 
PGD for adult-onset diseases, many 
stated that they objected because 
people with these diseases could still 
live full lives and because treatments 
were available or might become 
available.
  
“It gets into a very gray area when 
you’re saying ‘Now we’re going to 
have a child who is going to be sick 
from day one, and it’s going to be 
sick for it’s whole life’ versus ‘Now 
we’re going to have a child that’s 
going to be healthy for 40 years, 
and maybe by then we’re going to 
have a cure for cancer.’”
female participant from mixed sex/
race focus group, Massachusetts
Th is opinion was not unanimous, 
however. Some members questioned 
why using reproductive genetic 
testing to avoid the birth of a child 
at risk of cancer was ethically less 
acceptable than other technology 
aimed at eliminating cancer.  Th ose 
who expressed these opinions were 
more oft en men, and frequently had 
a personal experience with an adult-
onset disease. 
“It’s kind of  interesting that it 
would be okay for us to solve colon 
cancer in 40 years, but why couldn’t 
we solve it before it started?  Why is 
that not acceptable?  I mean, if  we 
have a cure for it, isn’t this truly a 
cure?  It’s a preventative cure, like 
living my life differently so I don’t 
get colon cancer.  Then your life 
was different from the beginning, 
we selected it that way, so you 
didn’t have that.  It’s an interesting 
thought.”
participant from male focus group, 
Colorado
Appropriate Uses
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Many focus group, interview, and 
town hall participants characterized 
using prenatal testing or PGD to 
avoid having children with obesity 
or depression as “too much picking 
and choosing” and “like shopping for 
kids.”  
“I am very uncomfortable with 
[using reproductive genetic testing 
to avoid] obesity, depression, those 
types of  things…that is too big of  
a decision to give those parents, I 
mean, to say this child can’t exist 
because of  these things or those 
things.”
participant from Mexican 
American female focus group, 
California
While many focus group 
participants initially expressed 
disapproval of the use of genetic 
testing to identify genetic risks 
for obesity or depression, further 
discussion oft en led to greater 
ambivalence about these uses.  For 
example, the discussions about the 
use of reproductive genetic testing 
for obesity might begin with one 
participant calling it “vain” and 
others countering that it was a 
legitimate health concern, leading 
some group members to express 
the opinion that both points of 
view were defensible.  Similarly, 
participants would use terms such 
as “quality of life,” “life-threatening” 
and “severe” only to discover that 
they each defi ned these terms 
diff erently.
Sex
Genetic testing can be used to 
identify the sex of embryos and 
fetuses.  Information about the sex of 
embryos can be used to select 
which embryos to transfer into 
a woman’s uterus.  Information 
about the sex of a fetus is most 
oft en obtained to satisfy parental 
curiosity but may also be the basis 
for a decision to have an abortion.  
Attitudes about genetic testing for 
sex are particularly interesting since 
it is the only reproductive genetic 
test currently in use that identifi es 
a genetic characteristic unrelated 
to health.2  All study populations 
were asked to comment on the use 
of PGD for sex selection, and survey 
and town hall participants were also 
asked about whether they approved 
or disapproved of prenatal genetic 
testing to identify sex.  
Focus group participants and 
particularly families aff ected by 
genetic diseases tended to group 
sex with socially desirable traits and 
were generally unsupportive of using 
PGD for this purpose.  A woman 
who had not yet had a successful 
outcome following PGD had a strong 
negative reaction to the use of PGD 
for non-medical sex selection.
“I think that’s completely stupid.  In 
a case like [hemophilia], where the 
sex of  the child affects the health of  
the child, yes.  But not for any other 
reasons.  That would be horrible.”
PGD patient (interview)
Health-care providers also had 
reservations about the use of PGD 
for non-medical sex selection.  
“I went into medicine and into 
science to diagnose, and treat, and 
hopefully cure disease.  And the 
last time I checked, gender wasn’t a 
disease.”
PGD provider (interview)
“We have spoken and discussed this 
extensively at our team meetings 
because we are torn between 
denying a patient care that they 
ask us for, and the somewhat 
distasteful idea that one gender 
is preferred to another in some 
cultures.”
PGD provider (interview)
While most of the participants 
in focus groups and interviews 
were quite negative about sex 
selection, fully 40 percent of 
surveyed Americans said that it 
was appropriate to use PGD to 
select the sex of a child (Figure 
3.1).  A discussion of who these 
“approvers” are follows below in 
the discussion of demographic 
characteristics.  Participants in the 
online town halls were asked about 
their approval for using PGD for sex 
selection before and aft er the online 
discussions.  Th ere was a marked 
decline in the number of participants 
“approving” of this use of PGD aft er 
the discussions, with numerous 
participants changing their opinion 
from “agree” to “strongly disagree.” 
Trait Selection
 
All data indicate that most 
Americans disapprove of the use of 
hypothetical reproductive genetic 
testing to select socially desirable 
traits such as intelligence, strength, 
or hair and eye color.  Focus group 
and interview participants described 
these uses as “selfi sh,” “vain,” 
“greedy,” “egotistical” and “frivolous.” 
Similarly, town hall participants 
objected to using these tests for traits 
because they viewed these uses to be 
“trivial,” “narcissistic” and “elitist.” 
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“If  you are going to get pregnant 
to have a baby just because it is 
going to have blue eyes and it is 
going to be perfect, I think there is 
something wrong with you because 
you should have a baby [to love 
it]…If  you are going to be very 
selective as to aesthetic, that’s 
not right.  You shouldn’t even be 
considering being a parent.”
participant from Mexican 
American female focus group, 
California
“I think if  parents are doing it for 
selfi sh reasons — like if  they want 
to have the best-looking kids on the 
block — I think there should be a 
line drawn there.  That’s not for the 
health of  the child:  that’s for the 
vanity of  the parents…[If] I want 
the tallest kids because I want my 
kid to be a basketball player - that, 
I think, is over the bounds.”
PGD patient (interview)
In spite of these strong 
sentiments, more than one-quarter 
of survey participants supported the 
use of prenatal genetic testing to fi nd 
out whether a fetus has desirable 
characteristics like intelligence 
or strength, and more than one-
quarter support the use of PGD to 
select for these traits (Figure 3.1).  
Th e discussion on demographic 
characteristics that predicted 
approval for trait selection is below.
The Slippery Slope 
“[T]o me, it’s like the slippery slope, 
O.K., so we start [with] mental, 
physical deformities — what’s next, 
you know?  Oh, we don’t like kids 
with blond hair.”
participant from Mexican 
American male focus group, 
California
Th ree-quarters of survey 
respondents agreed or strongly 
agreed with the statement that 
“Technology will inevitably lead to 
genetic enhancement and designer 
babies” (Figure 3.2). Aft er controlling 
for other variables, agreement with 
this statement varied very little, with 
the exception of education.  Higher 
levels of education were associated 
with a lower likelihood of agreement 
that genetic technologies would 
inevitably lead to “designer babies.”
Focus group and town hall 
participants were clear that it is 
not the technologies themselves 
that people fear, but rather that 
unrestrained human selfi shness 
and vanity will drive people to 
use reproductive genetic testing 
inappropriately.  Th ey believed that 
the technology is being developed 
for good purposes, but human vices 
will result in consumer demand for 
capricious uses.  
“You’re trying to get rid of  this 
terrible burden on your children, 
but at the same time, I don’t put as 
much faith in humanity, because 
people are greedy.  I mean, we’re 
just inherently greedy people and 
it’s never going to be enough.”
participant from young male focus 
group, Tennessee
“I would be lying if  I said I hadn’t 
encountered parents who made 
choices based on delusions and 
dreams. We’re not computers. It’s 
not only factual, logical issues we 
take into account.”
health-care provider from Seattle 
town hall
What Explains Differences in 
Opinions about Appropriate 
Use?
Th ere is huge diversity of opinion 
about which uses of reproductive 
genetic testing are and are not 
acceptable, but what accounts for 
this diversity of views?  In order to 
understand this diversity, we looked 
at the frequency of responses by 
a variety of socio-demographic 
Appropriate Uses
Figure 3.2: Percent Who Agreed with the Statement “Reproductive 
Genetic Technology will Inevitably lead to Genetic Enhancement 
and Designer Babies.”
Source: 2004 survey
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characteristics to see what 
characteristics were associated with 
particular views about reproductive 
genetic testing.
Sex, Race and Age
Approval for reproductive 
genetic testing for a fatal childhood 
disease and for tissue-matching 
is universally high (Figures 3.3 
and 3.4, and Tables 3.2 and 3.3).  
When a multi-variate regression 
was performed, diff erences in 
sex, race and age did not explain 
diff erences in attitudes about the use 
of reproductive genetic testing for 
fatal disease and tissue-matching.  
Th e only statistically signifi cant 
diff erence was that women were 
slightly more approving than men 
of prenatal genetic testing for tissue 
matching. Support was lower for 
reproductive genetic tests for adult-
onset diseases, sex and desirable 
traits; however, there were some 
interesting diff erences by sex, race 
and age.  Men and Hispanics had a 
higher level of approval for testing 
for adult-onset diseases.  Men were 
more supportive than woman of 
using prenatal genetic testing and 
preimplanatation genetic diagnosis 
for sex.  Whites were least supportive 
of using reproductive genetic tests 
for sex and hypothetical traits.  
Religion
 Among religion groups, 
Fundamentalist and Evangelical 
Christians were the least supportive 
of using these technologies for any 
reason.  Aft er controlling for other 
variables, being a Fundamentalist 
or Evangelical Christian was 
associated with a greater likelihood 
of disapproval for all uses of 
reproductive genetic testing.  Th e 
diff erences in attitudes between 
Fundamentalist and Evangelical 
Christians and all other religion 
groups is largest for PGD or 
prenatal genetic testing for fatal and 
adult-onset diseases and shrinks 
for testing for hypothetical traits 
(Figure 3.5 and Tables 3.2 and 3.3). 
While support for testing for traits 
is lowest among Fundamentalist and 
Evangelical Christians, fully one-fi ft h 
still approve of this use of PGD.
Figure 3.3: Approval of PGD for Different Purposes by Sex
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Respondents who did not have a 
religious affi  liation had the highest 
levels of support for the use of both 
prenatal genetic testing to fi nd 
out the sex of a fetus and PGD to 
select sex of an embryo.  Protestant 
participants reported higher levels 
of approval for testing for traits than 
other religious affi  liations. 
Income and Education
Some interesting diff erences were 
observed by education and income.  
As the level of education increased 
among respondents, approval for the 
use of both prenatal genetic testing 
and PGD to identify fatal childhood 
disease increased (Tables 3.2 and 
3.3).  In contrast, respondents with 
either no or only some college 
education showed greater levels of 
approval for reproductive genetic 
testing for sex or hypothetical 
traits.  Once adjusted for other 
demographic characteristics, these 
diff erences remained signifi cant.  
Approval for reproductive genetic 
testing was relatively constant across 
income groups, with two notable 
exceptions.  First, approval for 
both prenatal genetic testing and 
PGD for a fatal childhood disease 
increased as respondents’ income 
increased.  Second, approval for 
testing for hypothetical traits was 
inversely related to income, such 
that a greater number of participants 
in lower-income groups approved 
of reproductive genetic testing for 
hypothetical traits (Tables 3.2 and 
3.3).  Both of these observations 
remained statistically signifi cant aft er 
adjusting for other demographic 
characteristics. 
Political Affi liation 
Republicans are less approving 
than Democrats and “others” of all 
uses of reproductive genetic testing, 
though a majority approved of PGD 
and prenatal genetic testing for 
health-related purposes (Figure 3.6).
Awareness of the Technology
Survey respondents who reported 
they had heard about PGD prior to 
the survey were slightly more likely 
to approve of the use of PGD for all 
purposes.  Th ere were no diff erences 
Appropriate Uses
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in approval for the use of prenatal 
testing for each of the given purposes 
based on prior awareness of prenatal 
genetic testing (Tables 3.2, 3.3). 
Table 3.2: Percentage of Approval for PGD by Purpose and 
Demographic Characteristics
Demographic Characteristics Fatal HLA 
Match
Cancer Sex Traits
Total 67.6 65.5 57.8 39.9 27.9
Sex Men 69.8 64.1 62.7 45.2 33.1
Women 65.6 66.7 53.3 35.0 23.2
Age 18-29 68.9 64.4 59.0 41.0 27.4
30-49 69.3 65.8 57.5 41.1 27.0
50+ 65.1 65.7 57.6 37.9 29.2
Race / 
Ethnicity
White 68.3 65.3 56.6 38.6 25.3
Black 65.3 65.5 59.3 44.7 33.9
Hispanic 67.5 69.0 62.3 41.6 34.8
Religion Protestant* 73.5 70.2 61.5 43.0 30.0
Fund/Evang** 48.6 51.2 42.3 27.2 20.7
Roman Catholic 67.1 68.6 57.0 39.4 27.3
Other Christian*** 64.3 66.4 58.3 39.4 28.1
Other (Non 
Christian)
74.8 61.4 62.1 43.4 28.3
No Religion 79.9 71.0 69.2 48.0 32.7
Income Under 25k 64.9 67.3 58.1 41.1 32.0
25k-49k 67.4 65.4 57.7 38.4 26.6
50k-74.9k 66.9 61.2 57.3 39.6 26.0
75+k 74.6 66.7 58.4 40.8 24.3
Education No College 63.8 65.5 57.3 39.2 30.4
Some College 68.3 65.0 58.1 40.3 27.5
College 72.5 66.6 58.0 37.2 21.9
Post Grad 76.9 64.5 60.0 46.8 26.5
Political
Affi liation
Republicans 60.1 57.6 51.1 32.6 25.5
Other 64.6 62.8 58.5 38.3 26.6
Democrats 72.2 70.5 61.8 45.0 32.4
Aware PGD 73.1 69.3 62.8 43.8 32.6
Source: 2004 Survey 
* Protestant includes respondents who self-identifi ed as Protestant, excluding those who additionally self-identifi ed as Fundamentalist or Evangelical.
** Fundamentalist/Evangelical includes all Protestant or Other Christian respondents who additionally self-identifi ed as either Fundamentalist or Evangelical.
*** Other Christian includes all who self-identifi ed as Other Christian, excluding those that additionally self-identifi ed as Fundamentalist or Evangelical.
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NOTES:
¹ Having a child with a specifi c tissue type is 
important to some parents because such a 
child could provide stem cells, usually from 
the umbilical cord, for an older sibling who 
is sick and in need of a stem cell transplant. 
Stem cells from a matched sibling donor 
are less likely to be rejected and more likely 
to be effective  than stem cells from an 
unrelated donor.
² The situations presented to research par-
ticipants were to identify sex in the absence 
of a sex-linked genetic disease such as 
hemophilia.
Table 3.3: Percentage of Approval for Prenatal Genetic Testing by 
Purpose and Demographic Characteristics
Demographic Characteristics Fatal HLA 
Match
Cancer Sex Traits
Total 73.2 71.5 59.9 51.3 28.4
Sex Men 73.7 68.8 64.1 56.9 33.8
Women 72.6 73.9 56.0 46.0 23.5
Age 18-29 74.5 71.9 62.6 55.3 27.3
30-49 74.0 70.5 59.5 51.5 26.9
50+ 71.5 72.3 58.7 48.6 30.7
Race / 
Ethnicity
White 73.8 71.5 58.9 49.8 25.2
Black 72.0 73.4 62.1 58.4 36.0
Hispanic 73.5 73.5 64.1 51.6 35.4
Religion Protestant* 76.9 76.3 62.2 53.1 30.1
Fund/Evang** 57.7 60.4 46.6 43.2 22.7
Catholic 74.9 75.9 60.2 50.0 27.1
Other Christian*** 69.4 70.4 56.1 49.8 26.3
Other (Non 
Christian)
79.4 64.3 66.1 54.8 31.1
No Religion 82.9 74.4 71.7 58.8 34.4
Income Under 25k 71.1 72.0 59.1 53.2 34.6
25k-49k 73.4 72.0 61.7 48.5 26.4
50k-74.9k 72.3 71.2 59.3 53.2 25.6
75+k 77.9 69.5 58.1 50.7 22.9
Education No College 70.2 72.1 59.9 50.9 32.4
Some College 73.5 71.5 60.6 52.0 27.2
College 77.6 73.3 57.7 48.7 19.8
Post Grad 79.9 65.3 61.1 55.5 26.5
Political
Affi liation
Republicans 67.5 65.4 54.9 45.4 23.0
Other 69.1 67.0 57.3 48.8 28.9
Democrats 76.4 74.6 63.3 54.5 33.6
Aware Prenatal Testing 75.7 72.7 61.0 51.4 27.5
Source: 2004 Survey
* Protestant includes respondents who self-identifi ed as Protestant, excluding those who additionally self-identifi ed as Fundamentalist or Evangelical.
** Fundamentalist/Evangelical includes all Protestant or Other Christian respondents who additionally self-identifi ed as either Fundamentalist or Evangelical.
*** Other Christian includes all who self-identifi ed as Other Christian, excluding those that additionally self-identifi ed as Fundamentalist or Evangelical.
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“I guess it depends on where you 
really think your baby starts.  Does 
it start at the egg and the sperm or 
does it start once it actually starts 
looking like a little baby at nine 
weeks old…”
participant in Black female focus 
group, Tennessee
Americans have deeply held, and 
widely divergent, views about the 
moral worth of both the human fetus 
and embryo, and it is oft en assumed 
that those beliefs determine people’s 
perspectives about various forms of 
reproductive genetic technologies. 
Th e notion that people’s views 
about the appropriateness of 
using reproductive genetic testing 
are determined by their views of 
the moral status of embryos and 
fetuses – was explored in both the 
qualitative and quantitative research. 
During the focus groups, 
participants were asked to comment 
on hypothetical situations in 
which termination of a pregnancy 
and destruction of embryos were 
potential outcomes following 
genetic testing.  In the discussion 
about prenatal testing, participants 
were asked to talk about what a 
hypothetical couple should do with 
information that their fetus has 
a specifi c genetic disease.  Next, 
they were asked to discuss what 
they thought about the use of 
preimplantation genetic diagnosis 
(PGD) to produce healthy children. 
Finally, participants were  asked 
what a couple ought to do with 
excess embryos – both aff ected and 
unaff ected – following PGD.  During 
the town hall meetings, participants 
expressed their views on the moral 
status of embryos and fetuses and the 
role that plays in decision making.
Although the moral status of 
fetuses and embryos is an important 
part of people’s assessment of the 
acceptability of using reproductive 
genetic testing, numerous additional 
issues (discussed in Chapters 3, 5, 
6 and 7 of this report) seemed to 
infl uence focus group and town 
hall participants’ opinions.  Th us, 
to obtain a quantitative assessment 
of the relationship between people’s 
views about the moral status of 
embryos and the acceptability of 
using PGD, survey respondents 
were asked about their views on 
abortion, the beginning of life, the 
moral status of embryos and fetuses 
at various stages of development 
and appropriate uses of prenatal 
testing and PGD.  Responses to these 
questions were then cross-tabulated.
The Moral Status of the Fetus
Prenatal genetic testing has been 
a routine part of prenatal care for 
decades.  Th e number of conditions 
that can be tested for continues to 
grow, and the stage in pregnancy 
when testing can occur is being 
pushed back into the fi rst trimester.  
In very rare instances, information 
about a genetic abnormality in utero 
can facilitate early intervention.  
Additionally, some families fi nd 
value in early identifi cation of a 
genetic abnormality because it gives 
them the opportunity to plan for the 
birth of a special-needs child.  What 
concerns some people, however, is 
that if prenatal testing identifi es an 
aff ected fetus, parents may consider 
terminating the pregnancy, or even 
be encouraged by others to do so.  
Of greater concern to some is the 
possibility that a woman might 
choose to terminate a pregnancy 
because the fetus does not have the 
desired genetic characteristics, such 
as the “right” sex.
To begin exploring Americans’ 
opinions about the use of prenatal 
genetic testing and how that may or 
may not correlate with their views on 
the moral status of the fetus, focus 
group participants were asked to 
talk about a hypothetical scenario in 
which a pregnant woman discovers 
through prenatal testing that her 
fetus is aff ected with a genetic 
disease.  Participants were told that, 
in addition to preparing for the birth 
of an aff ected child, terminating 
the pregnancy was also a potential 
choice.  Some participants in almost 
every focus group expressed the 
view that abortion under these 
circumstances is immoral and that 
once pregnant, carrying to term and 
giving birth is the only option.  Th is 
viewpoint was held frequently but 
not exclusively by individuals who 
defi ned themselves as Christians.
“I approach this from a non-
religious point of  view…I don’t 
really believe in abortion, and it’s 
not a religious view; it’s just a view 
that I think life is great, and I think 
everybody should be alive.  I think 
the more life the better, you know?  
And let the life run its course.”
male participant from mixed sex/
race focus group of  people 55 yrs 
and older, California 
Many focus group participants 
who were opposed to abortion 
said they would personally refuse 
prenatal testing if there were no 
treatment options, such as fetal 
surgery, and abortion was the 
only available intervention.  Some 
participants also pointed out that 
carrier testing and prenatal maternal 
Chapter 4: Views About Embryos and Fetuses 
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serum screening seem harmless 
because they are “just blood tests,” 
but they can lead to invasive prenatal 
genetic testing.  Prenatal genetic 
testing, if positive, could result in a 
very profound and diffi  cult decision 
to terminate a wanted pregnancy.  
Some participants were concerned 
that routine prenatal genetic testing 
might create the “temptation” for 
women to abort if the results are 
positive.
For other focus group 
participants, abortion was perceived 
to be a tragic, yet acceptable, 
alternative, particularly when its 
goal is perceived as preventing the 
suff ering of a child.  Numerous focus 
group and interview participants 
stated that abortion might be the 
best choice when a fetus is diagnosed 
with a severe, life-threatening 
disease.  
“I probably would abort because 
I wouldn’t want to see the baby 
suffering…when I know I could 
have...[given] the baby their wings 
and just let them just avoid that 
suffering.”
participant from Black female 
focus group, Michigan 
Both points of view – that ending 
a pregnancy is taking a life and that 
it is the best choice to make when 
the alternative is the birth of a child 
with a severe, life-threatening illness 
– were expressed by individuals 
with all socio-demographic 
characteristics.  
Many focus group participants, 
without prompting, considered ways 
that couples could avoid this choice, 
and recommended that carrier 
testing be available prior to 
pregnancy so that couples can know 
their risk before they are “already 
pregnant.”  
For a very small minority, even 
a full-term fetus does not have the 
same moral worth as a born baby 
and, therefore, abortion is not a 
morally laden choice. 
“…brace yourselves, ladies, some of  
you are not going to agree with me.  
I do not think an embryo is a baby.  
A baby is not a baby until it is born 
and it is alive.  That’s my view, and 
that’s why I don’t put my view on 
anyone else.  That’s mine.” 
participant from White female 
focus group, Michigan
The Moral Status of the Embryo
PGD was originally developed 
to create an alternative to prenatal 
testing and abortion for couples 
at known risk of having a child 
with a genetic disease.  To better 
understand Americans’ views about 
the moral status of embryos, and 
how the American public views PGD 
in comparison with prenatal testing 
followed by abortion, focus group 
participants were asked to discuss a 
scenario in which a couple at risk of 
having a child with a genetic disease 
was considering whether or not to 
use PGD.  Th ey were then asked 
to compare the two approaches 
to avoiding having a child with a 
genetic disease.
Some focus group participants 
stated their belief that from the 
moment of conception embryos have 
the same moral value as all human 
beings, and therefore rejecting some 
embryos through PGD is 
unacceptable.  
“[Y]ou formed a child.  The sperm 
and the egg have come together 
and essentially [through PGD] you 
get rid of  a child, to me.  Not to 
everybody because eight cells might 
not make up a child to you, but to 
me, I have to really think through 
it.  I mean where is my kid going?  
Are you going to fl ush him down the 
toilet?”
participant from Black female 
focus group, Tennessee
In fact, some focus group 
participants who adamantly 
believe that embryos have the full 
moral worth of a child argued that 
PGD is ethically less acceptable 
than prenatal testing followed by 
abortion, because it may result in the 
destruction of multiple embryos.
“I think the difference is that when 
you’re testing the embryo at four 
months, you’ve only created one 
potential life there.  When you do 
it in the dish, fi ve, six, seven, eight?  
Those are all potential children.  So 
to me, that’s the difference.  You 
have now created more that are 
going to be destroyed.”
female from mixed sex/race focus 
group, Massachusetts 
“What I would call [PGD] is selective 
abortion because I believe that 
life begins at conception, which is 
when the sperm and the egg unite.  
So, whether it is eight to ten cells, 
or a fully developed baby, I think 
what you have done is scientifi cally 
produce twenty embryos, which I 
would call a baby.”
participant from Evangelical 
female focus group, Colorado 
Other focus group and interview 
participants, including some who 
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had concerns about the morality 
of aborting an aff ected fetus, 
thought that there was a distinction 
between abortion and the loss of 
embryos through the PGD process.  
Th ey perceived PGD as ethically 
preferable because PGD does not 
require termination of a pregnancy.  
Th is view was expressed by many 
members of the general public in 
focus groups, health-care providers, 
families aff ected by genetic diseases 
and all of the PGD patients.  
“[P]reimplantation genetics has 
almost redefi ned that life, in 
my opinion, would start upon 
implantation and not upon 
conception.  Because it’s in a lab.  
An embryo at that stage cannot 
be sustained by itself.  If  it’s not 
implanted or frozen it will not turn 
into a human being.  It needs to be 
implanted into a woman in order 
for it to become a human, so that’s 
why I don’t have a problem with 
preimplantation genetics. “
Adult with genetic disease, 
interview
“I just keep thinking of  embryos 
and implanted embryos.  Those are 
very different things.”
female participant from mixed 
sex/race group, Massachusetts
A PGD specialist described 
in detail why he believes PGD is 
diff erent ethically from prenatal 
genetic testing:
Well, I think defi nitely there is 
[an ethical difference]…When we 
look at the embryo, the embryo 
is at the eight-cell stage, which is 
three days after the fertilization.  
Morphologically, this is a very much 
undifferentiated situation.  And this 
embryo, unless you transfer to the 
uterus, is not a viable embryo”
PGD specialist, interview 
PGD patients were even more 
adamant about the ethical diff erences 
they perceived between abortion and 
PGD. 
“[N]either of  us felt that the embryo 
was a living thing until it was living 
inside me.”
PGD patient, interview
“PGD…is more costly; almost as 
emotionally draining; and more 
painful, physically, than doing the 
prenatal testing, but ethically, I 
feel better about doing it.  Because 
I know that I’m not ending a 
life…to me, a ball of  cells is not 
a child until it takes root and 
starts growing, so I don’t feel that 
I’m doing something bad or evil 
or unethical by not using certain 
embryos.  So I just feel I’m doing 
everything I can to create a healthy, 
happy child, rather than wait and 
fi nd out if  I’ve created a healthy 
and happy child.”
PGD patient, interview
In their discussions about 
PGD, focus group and interview 
participants were asked to think 
about what to do with both aff ected 
and unaff ected embryos left  over 
from the PGD process.  Th e majority 
believed that the whole point of 
PGD was to avoid the transfer of 
aff ected embryos, so these embryos 
should not be used for reproductive 
purposes.  Participants repeatedly 
suggested that aff ected embryos 
should be donated for disease 
research.  Th e most common 
suggestion for what to do with extra 
unaff ected embryos was to freeze 
them for future transfer.
Occasionally a participant would 
recognize the ethical dilemma 
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“What happens [once embryos 
are created through PGD]?…I 
acknowledge it is a child, but 
then I don’t acknowledge it is a 
child.  When it turns out to [be 
affected], fl ush it or whatever; or I 
do acknowledge it is a child when 
you want to put that good child in 
my body, and the bad children, you 
know? [W]hat gets me is that ethical 
part of  she has got those fi ve sickle 
cell kids and the one that doesn’t 
have it, you want that one. That 
is your desire, and we live happily 
ever after.  But what happens to 
them?”
participant from Black female 
focus group, Tennessee 
Views about the Moral Worth of 
Embryos and Fetuses
Views about the moral status 
of embryos clearly play a part in 
people’s thinking when they assess 
the acceptability of using PGD, but 
how big a part?  Do people’s views 
about the moral status of embryos 
predict their opinions about the 
appropriate use of PGD, or are there 
other factors at play?
To assess Americans’ views on the 
moral status of human embryos and 
fetuses in the general population, 
respondents to the 2004 survey 
were asked to rank, on a fi ve-point 
scale, the moral worth of an embryo, 
a fetus at various stages, and a 
born baby (Figure 4.1).  Survey 
results indicate that the stage of 
development makes a diff erence 
in people’s assessment of moral 
worth.  In rating moral worth, the 
proportion of respondents assigning 
maximum moral worth increased 
with increasing developmental 
age.  As expected, a large majority 
(86 percent) ranked a born baby as 
having maximum moral worth on a 
fi ve-point scale.  Forty-seven percent 
of respondents assigned an embryo 
in the womb maximum moral worth 
compared to 26 percent who rated 
an embryo in a petri dish as having 
maximum moral worth.  
Because the use of PGD generally 
involves the destruction of human 
embryos,1  if opinions about PGD 
are principally driven by views 
on the moral status of the human 
embryo, one would predict that 
those who believe that an embryo 
in a petri dish has maximal moral 
worth would disapprove of PGD 
regardless of why it is being used; 
however, this is not the case.2   
Th ose who felt that embryos in 
vitro have maximum moral worth 
were less likely than those who 
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Figure 4.2: Moral Worth of an Embryo in a Petri Dish
Source: 2004 Survey
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ranked embryos with less moral 
worth to approve of any use of PGD 
(Table 4.1).  However, slightly more 
than half of the respondents ranking 
embryos with maximum moral 
worth approved of PGD for a fatal 
childhood disease (52 percent), for 
HLA matching (54 percent) and 
nearly half (46 percent) approved 
of PGD for an adult-onset disease 
(Figure 4.2, Table 4.1).  Th us, this 
level of approval of PGD does not 
support the notion that people who 
attach a high moral worth to the 
embryo necessarily reject PGD; 
other factors must be playing a 
strong role.
Approval for the fi ve proposed 
uses of PGD varied considerably 
among those who ranked embryos 
as having maximum moral worth, 
providing further support for the 
existence of factors other than 
moral worth in the determination 
of attitudes towards PGD.  Among 
those ranking embryos with 
maximum moral worth, approval 
for PGD to ensure a child will not 
have a fatal childhood disease was 
more than twice as high as approval 
for using PGD to select hypothetical 
traits such as intelligence or strength 
(Table 4.1).  A similar pattern was 
observed in responses from those 
who ranked embryos in a petri dish 
as having high, moderate, low or no 
moral worth (Table 4.1; Figure 4.3).
Further support for the notion 
that views about moral worth are 
not the primary drivers for views 
on PGD comes from those who 
disapprove or strongly disapprove 
of PGD.  A third of respondents 
disapproved or strongly disapproved 
of the use of PGD for a fatal 
Embryos and Fetuses
Figure 4.3: Level of Approval for PGD by Purpose: Comparing 
Respondents who Assigned Embryo in a Petri Maximum Moral 
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childhood genetic disease. Yet only 
38 percent of this group rated a 
human embryo in a petri dish as 
having maximum moral worth 
(Figure 4.4). 
Th ese data demonstrate that while 
views on the moral status of human 
embryos infl uence attitudes toward 
PGD, other factors are playing a 
major role in shaping these attitudes.  
NOTES: 
1 In the survey, preimplantation genetic 
diagnosis was defi ned as “genetic testing that 
is done on embryos produced through in vitro 
fertilization before they are transferred to a 
woman’s womb.  Based on the test results, 
parents can select which embryos to transfer 
into the woman’s womb.  For example, they 
may want to select only embryos with no 
genetic diseases, those of a specifi c sex, or 
those that have other characteristics.  Left over 
embryos may be discarded, frozen and stored 
for future use, donated to other couples, or 
used for research.”
 2 Similar analysis using prenatal genetic 
testing and views about the moral status of 
a human fetus is not possible because the 
questions about prenatal genetic testing were 
framed differently.  We asked whether it was 
appropriate to use prenatal genetic testing 
to fi nd out whether a fetus has a genetic 
alteration that causes illness, etc.  Finding 
out is not the same as making a decision to 
terminate and thus does not necessarily have 
the same moral implications.
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“Do we leave it to God, or is it up to 
us?” 
participant from Mexican 
American male focus group, 
California
Americans’ beliefs about how 
much we ought to attempt to control 
human reproduction and the 
genetics of the children we bring into 
the world fall across a very broad 
spectrum.  At one end are people 
who believe that using genetic 
testing to make reproductive choices 
amounts to “playing God.”  Th ose in 
the middle believe that some uses 
may be justifi ed but that humans 
need to be cautious stewards of any 
new technology.  At the other end of 
the spectrum are those who believe 
we should be using technology 
in every possible way that might 
advantage humans, including 
enhancing and improving the human 
species.  
“[I]t feels like we’re taking this 
incredible gift and process of  giving 
birth to a child, and turning it 
into a scientifi c process, and that 
completely goes against what I 
believe. I want to leave [the sex of  
a baby] up to whatever the Creator 
decides He wants to give me, and 
trust that there is a reason that I’m 
going to have a boy instead of  a 
girl.”
participant from White male focus 
group, Colorado
When focus group participants 
discussed the use of reproductive 
genetic testing, the notion of humans 
overstepping their appropriate role 
in the reproductive process was 
always mentioned.  Th is concern was 
expressed in either religious terms, 
for example, “playing God,” or in 
secular terms, such as “tampering 
with Mother Nature” or “interfering 
with natural selection.”  
In the 2002 survey, participants 
were asked what worried them 
most about the use of reproductive 
genetic technologies (Figure 5.1).  
When given the choice of four 
alternatives, 34 percent of Americans 
said that using reproductive 
genetic technology was too much 
like “playing God.” Th e only issue 
(among those choices off ered) that 
appeared to concern participants 
more was that the technologies could 
be used for the wrong purposes.  
Th e idea of “playing God” was 
most frequently mentioned by 
Evangelical Christian focus group 
participants, but was spontaneously 
mentioned during many of the other 
focus groups.  It is important to 
note that in all of our discussions 
with Americans, this phrase was 
consistently used as an expression of 
concern.  
Focus group discussions revealed 
that “playing God” means diff erent 
things to diff erent people.  As 
discussed in Chapter 4, some focus 
group participants equated the 
destruction of embryos and/or 
fetuses with murder.  For this group, 
“playing God” meant deciding who 
lives and who dies.  
“I don’t think that you can just 
discard an embryo that has been 
fertilized, or change that in any 
way because I just don’t believe 
that that is the way God intended 
it to be…Promote a healthy baby, 
I am all for it, but I just don’t think 
isolating and taking [embryos] out, 
deciding which ones to take and 
which ones you shouldn’t take — I 
think that’s an ethical thing, and 
I think that’s God choice and not 
mine, or the doctor’s or anybody 
else’s.”
participant from female Catholic 
focus group, Michigan
Chapter 5: Human Control Over Reproduction
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Table 5.1: Suffering is a Part of What Makes Us Human
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Others were concerned that these 
technologies can result in people 
making value judgments about 
who is fi t to be born.  Th is sends an 
inappropriate message that there are 
some lives not worth living.  Th is 
concern was expressed 
predominantly by Evangelicals and 
by Catholics.  
  
“…I would draw the line anytime 
that a life is being ended because of  
its assumed quality.”
participant from Evangelical 
female focus group, Colorado
“[W]e wanted to send all of  our 
children the message that quality of  
life is not measured by how many 
minutes you get on this planet, or 
how many of  those minutes are 
disease-free.  But rather by how 
much you have loved, and by how 
much you have been loved.  And 
in that respect, we feel that our 
children have a rich, happy life.”
mother of  child with cystic 
fi brosis who declined to use PGD 
(interview)
Numerous participants pointed 
out that we may not understand 
why people are aff ected by genetic 
disease, but everything that happens 
in life, including having a genetic 
disease, has a purpose as a part of 
God’s divine plan.   
“[D]o you trust God to have the best 
will, that what he has given you is 
the best thing that you can have, 
and to do the best you can with it, 
or do you want to keep intervening 
in situations, and change things, 
and not knowing whether you have 
the best wisdom or not?”
participant from Evangelical 
female focus group, Colorado 
* Protestant includes respondents who self-identifi ed as Protestant, excluding those who additionally self-identifi ed as Fundamentalist or Evangelical.
** Fundamentalist/Evangelical includes all Protestant or Other Christian respondents who additionally self-identifi ed as either Fundamentalist or Evangelical.
*** Other Christian includes all who self-identifi ed as Other Christian, excluding those that additionally self-identifi ed as Fundamentalist or Evangelical.
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I don’t agree with making your 
baby while it is in the womb 
because that is part of  the 
enjoyment…You can’t just go in 
and be like I want a baby with 
blue eyes, brown hair, can it be six 
foot tall, can it be like Omar Epps 
and look like Morris Chestnut…it 
all comes back to [the] religious.  
No matter what you have, God 
has blessed you with it.  And you 
should never be ashamed of  the 
way you look or your appearance or 
anything like that.”
participant from Black female  
focus group, Tennessee
Additionally, some focus group 
participants made clear that, for 
them, suff ering, disability and 
physical, mental and emotional 
challenges are a valuable part of life 
and contribute something special 
to individual lives, families and, 
collectively, to society.  Th ese people 
argued that human suff ering teaches 
individuals about overcoming 
obstacles and growing as human 
beings and contributes to a more 
humane world.  
“I think there are things we need to 
learn from our own trials…Maybe 
compassion as human beings, and 
that’s how we learn it.”
participant from Mexican 
American male group, California
Th e idea that suff ering is an 
essential part of life was explored 
in the 2004 survey.  Respondents 
were asked whether they strongly 
agreed, agreed, disagreed or strongly 
disagreed that “Suff ering is a part of 
what makes us human” (Table 5.1). 
A greater number of Fundamentalist 
and Evangelical Christians and 
Catholics  agreed with this statement 
compared to other religion groups. 
Americans over 50, and those with 
higher education and income, were 
slightly less likely to think suff ering 
is a part of what makes us human.  
Interestingly, there were virtually no 
diff erences by sex, race or political 
affi  liation in the way people think 
about the purpose of suff ering. 
In addition to perceptions about 
the purpose of suff ering, many 
Evangelical and other Protestant 
focus group participants said having 
a child aff ected by any disease has 
deep spiritual meaning.  It may be 
an opportunity to learn compassion, 
a test of faith for the parents, a 
testimony of the family’s faith to 
others as they learn to live with the 
burdens and blessings of having an 
aff ected child or an opportunity for 
God to perform a miracle.  Using 
technology to avoid these situations 
could be interpreted as a lack of faith 
in God’s plan for your life.
“…I believe that everyone is created 
differently, and there is a reason 
that people are born with whatever. 
Even if  it is cystic fi brosis, there is a 
reason that God has intended that 
person to have that, whether it be 
a testimonial kind of  a thing, or 
maybe it would make the quality of  
life better, knowing that you could 
die within like ten years, because I 
think a lot of  people just live like 
they can live forever…So I think 
everything has a purpose.”
participant from Evangelical 
female focus group, Colorado  
“God doesn’t put anything on you 
that you can’t bear.  And sometimes 
pain is just something you have to 
bear through…it is just something 
that everybody has to learn to live 
with…”
(Protestant) participant from Black 
female focus group, Tennessee
“To me, [parents of  an affected 
child] were blessed with a child, 
and it’s God’s will how that child 
comes out.  It might be a test for the 
parents.”
participant from Mexican 
American male focus group, 
California
Other focus group and town 
hall participants expressed their 
discomfort with reproductive 
genetic testing in secular rather than 
religious terms.  Th ey stated their 
belief that using these technologies 
to infl uence who is born is 
tampering with nature or fate and 
could have repercussions we cannot 
begin to understand.  
Some participants said there is 
divine wisdom in the design of the 
world, or in secular terms, that there 
is a balance to nature.  Similarly, 
the idea was expressed that human 
wisdom is fl awed, and that we may 
think we are using sound judgment 
when we use these reproductive 
genetic testing technologies, but 
we will be tempted to use them 
for “selfi sh” reasons and in ways 
that reinforce harmful stereotypes.  
Additionally, participants stated that 
the ability to select for or against 
specifi c traits is unlikely to turn out 
the way people plan because too 
Human Control
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many factors work together to create 
a whole person.  For instance, a 
person selected for genetically high 
intelligence may contribute little 
to the world without ambition and 
moral values. 
“I don’t know if  I can put my fi nger 
on it, but there is something that 
just seems kind of  off  about the 
whole process of  us pulling out 
sperm and eggs, and mixing them 
all up and picking the one we 
like best, without even trying to 
take it to a really deep religious or 
philosophical level.”
participant from White male focus 
group, Colorado
“[A] lot of  this stuff  is, in my own 
personal opinion, mankind trying 
to step above God or natural order, 
the way things were supposed to be 
created, how things were naturally 
created within the Bible.  Man is 
trying to take it to his own context, 
and as a result, man is going to 
doom himself  because of  trying to 
go above and beyond God, and go 
against natural order, and the way 
things are supposed to be done.”
participant from young male focus 
group, Tennessee
“You have a doctor who is picking 
the cells that are going to be 
implanted, as opposed to the body 
naturally picking what’s going to 
happen.”
participant from female focus 
group, Massachusetts
When challenged by other 
participants, however, some of the 
participants who thought that using 
reproductive genetic testing was 
unnatural or “playing God” agreed 
that taking control of reproduction 
to limit disease is not radically 
diff erent from other medical 
interventions.  
A few focus group participants 
argued that God has given us these 
tools and leaves it up to humans to 
use them wisely.  Eliminating serious 
genetic disease is a wise and an 
appropriate use of the technology.
“[I]f  we’re going to leave it to God, 
God’s putting this knowledge in 
our path.…God’s giving us the 
knowledge to fi gure it out.”
participant from Protestant female 
focus group, Massachusetts 
“You know what it is?  It’s the old 
argument, you know, if  God wanted 
you to fl y, he’d give you wings.  
Well, you know, we got past that.  
We fl y now.”
male participant from older mixed 
sex/race focus group of  people 
over 55, California
“We eliminated small pox and I 
didn’t see anybody crying about 
that.”
participant from Mexican 
American female focus group, 
California
“How is stopping it [technology] not 
playing God?”
participant from young female 
focus group, Colorado
Is This the Next Step in Human 
Evolution?
“Down the road, and this is very far 
down the road, I think this is the 
way the human species is going to 
evolve.  We have…met the limits of  
our evolution in the old fashioned 
ways.”
PGD provider (interview)
At the other end of the spectrum 
were focus group participants, 
mostly male, who argued that 
human intervention in reproduction 
can lead to effi  cient and vast 
improvements in human health, 
and we have an obligation to pursue 
technological progress. 
“I think if  the question on the 
table is should they be allowed 
to increase intelligence, I say 
yes…I agree…people who are 
more intelligent generally are more 
aware; they live life a little bit more 
fully…[If] we can make children 
more intelligent, sure, make them 
more intelligent.  Let them really 
live life; enjoy things; let them stop 
and smell the roses, and know what 
that means, and not just be brutish 
louts walking down the streets 
stealing hubcaps, you know?”
male participant from older mixed 
sex/race focus group of  people 
over 55, California
“It’s kind of  funny that I guess 
humans will do this to animals to 
make more productive cows, more 
productive chickens that have 
bigger breasts for meat and stuff  
like that, and we can look at that as 
an improvement of  the animal for 
a variety of  purposes, but we kind 
of  refuse to put ourselves in that 
animal category, and we refuse to 
say ‘why don’t we make a smarter 
kid?’  As a teacher, I would love to 
have a room full of  smart kids.  I 
have plenty on the other side, you 
know?”
participant from White male focus 
group, Colorado
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“[I]f  there is a possibility of  a way 
that you can actually have a better 
person, I don’t see how come we 
would not want to select to have a 
better person.”
participant from Black male 
group, Tennessee 
Th is notion was tested in the 
2004 survey, in which Americans 
were asked whether they strongly 
agreed, agreed, disagreed or strongly 
disagreed with the statement:  
“Reproductive genetic technology 
is potentially the next step in 
human evolution.”  Americans 
are almost evenly split between 
agreeing and disagreeing with this 
statement (Table 5.2).  Th ere was 
very little variation by demographic 
characteristics with two notable 
exceptions.  Sixty-one percent 
of people who had no religious 
preference agreed with this 
statement, while only 41 percent 
of Fundamentalist or Evangelical 
Christians agreed.  Th ere was a 12 
percentage point diff erence between 
Democrats and Republicans, with 
58 percent of Democrats agreeing, 
compared to only 46 percent of 
Republicans agreeing.  In addition, 
Whites were slightly less likely than 
Blacks or Hispanics to agree with 
this statement.
Table 5.2: Reproductive Genetic Technology is Potentially the 
Next Step in Human Evolution















Other (Non Christian) 56.7
No Religion 60.9















* Protestant includes respondents who self-identifi ed as Protestant, excluding those who additionally self-identifi ed as Fundamentalist or Evangelical.
** Fundamentalist/Evangelical includes all Protestant or Other Christian respondents who additionally self-identifi ed as either Fundamentalist or Evangelical.
*** Other Christian includes all who self-identifi ed as Other Christian, excluding those that additionally self-identifi ed as Fundamentalist or Evangelical.
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“I generally think this is marching 
down the road of  the end of  
mankind.”
participant from young male focus 
group, Tennessee
Th e American public has 
both hopes and fears about the 
implications of using reproductive 
genetic testing.  Many are extremely 
optimistic about the potential to 
enable families to have healthy 
children and reduce the physical 
and emotional burdens caused by 
genetic diseases.  Some even believe 
the technology is a step towards 
improving the human condition 
by leading to increased life spans 
and improved quality of life.  But 
many are troubled by the potential 
for adverse social consequences 
of widespread use of reproductive 
genetic testing.  
Will a society that can “pick and 
choose” the genetic characteristics 
of the next generation become less 
accepting of genetic diff erences, 
neglect those with genetic disease, 
view children as products and 
hold parents responsible for the 
birth of less than perfect children?  
Additionally, many are concerned 
that selecting for or against 
certain genetic alterations might 
inadvertently make humanity more 
vulnerable.  For example, we might 
make humans more susceptible to 
infectious disease.  Finally, many fear 
the possibility that if the government 
controls these technologies, they 
could be used for nefarious purposes 
such as the Nazi eugenics movement 
or as genocidal weapons. 
To uncover and further explore 
people’s perceptions about the 
social implications of reproductive 
genetic testing, participants in the 
focus groups, interviews and town 
hall meetings were asked to discuss 
their hopes and fears about this 
technology.  Subsequently, survey 
respondents were queried about 
their levels of concern about these 
issues.
Will We Lose Diversity?
“What are we going to do, go 
through and clean out every single 
one of  these until we have this 
perfect person?  What’s the fun in 
that?  What are we going to do, 
be all bland, homogenous white 
people?  Where is going to be the 
diversity? I like diversity in my life.”
participant from young male focus 
group, Tennessee
 
Focus group participants were 
worried about a world in which we 
scrutinize DNA to see who passes 
over the genetic bar and is allowed to 
gain entry into the world.   
A common remark among focus 
group and town hall participants 
was that they did not want a world 
of “blonde haired, blue-eyed people.”  
Th ey thought that the world was 
a better place for being diverse, 
and they feared that reproductive 
genetic technologies could lead to a 
narrowing defi nition of who is fi t to 
be born and a loss of the beauty and 
richness of human diversity.
Some focus group and town hall 
participants pointed out that much 
of what we consider extraordinary 
about some individuals could also be 
interpreted as genetic fl aws.  Using 
reproductive genetic technologies 
to eliminate these fl aws means 
eliminating these individuals, who 
can make major contributions to 
society. 
“What about someone like 
[physicist] Stephen Hawking?  
Someone might have chosen not 
to continue that pregnancy, and 
we would have missed out on a 
genius.”
participant in Kalamazoo town 
hall 
Some Americans, especially 
those in families aff ected by genetic 
diseases, were concerned that 
routine use of genetic testing would 
eventually reduce the number or 
even lead to the elimination of 
people with genetic diseases.  
“And people with genetic conditions 
have wonderful lives, and they can 
lead productive lives, and it’s not a 
reason to really eliminate a genetic 
condition…because then you start 
to eliminate a different segment of  
the population that deserves to be 
there.”
adult with genetic disease 
(interview)
Th e potential that use of these 
technologies could result in a loss 
of human diversity is of concern 
to three-quarters of survey 
respondents (Figure 6.1).  Th is is 
of greatest concern for women of 
reproductive age, Republicans, and 
Fundamentalist and Evangelical 
Christians and Catholics.
Concerns about loss of diversity 
extended to the possible biological 
consequences of reproductive genetic 
technology.  A few participants cited 
research linking a single sickle-cell 
gene mutation with resistance to 
malaria.  
Chapter 6: Implications for Individuals, Families 
and Society
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“But we all know for a fact that 
humanity is strong because of  
diversity.    Now it may not be as 
clean.  Yes, we have kids with cystic 
fi brosis.  We have kids with Down 
syndrome, but diversity is what 
makes us strong…we don’t know 
what the future implications of  our 
eliminations are.”
participant from White Protestant 
female focus group, Massachusetts 
“To have one copy of  the [cystic 
fi brosis] gene actually offers 
protection against certain types of  
plagues…And in fact, that’s why 
cystic fi brosis is still with us today. 
Carriers have a survival advantage 
over people who are not carriers. 
When you change one thing in a 
very complex system, you sometimes 
inadvertently change things that 
you didn’t want to change.”
mother of  three children with 
genetic disease (interview)
Some focus group and town 
hall participants also expressed the 
fear that widespread availability 
of reproductive genetic testing 
combined with a preference for male 
children in some cultures could lead 
to signifi cant sex ratio imbalances.  
Th ese imbalances could lead to 
societal dysfunction if most people 
selected one sex over the other.  
“There are so many examples of  
what’s already happened with 
people thinking that men are 
better than women and women 
are inferior.  I mean in China, you 
know they were throwing away 
kids because they were girls, and 
now you’re giving people the power 
to just not even have to deal with 
accepting what they have.”
participant from young female 
focus group, Colorado
Again, survey fi ndings confi rm 
that over two-thirds of Americans 
are concerned about use of this 
technology leading to an imbalance 
in the sex ratio (Figure 6.1). 
Discrimination and 
Stigmatization of the Disabled  
“I think socially we have to be 
very aware that we’re not trying to 
eradicate all diseases, because we 
don’t want it [to be] that we don’t 
accept people in our society that 
have a disease...I wouldn’t want 
to see a society that really further 
stigmatizes families or children or 
adults that do have a disease.”
genetic counselor (interview)
Of the seven concerns identifi ed 
in the qualitative research and 
tested in the survey, fear that use 
of this technology could result in 
discrimination and stigmatization 
of the disabled is of most concern 
to survey respondents.  Fully 81 
percent of surveyed Americans were 
very concerned or concerned that 
expanded use of reproductive genetic 
testing could lead to increased 
discrimination against the disabled 
(Figure 6.1).  Females, those with less 
education and Fundamentalists and 
Evangelical Christians were most 
concerned about discrimination.  
Members of diff erent races were 
equally likely to be concerned about 
discrimination.
Additionally, data from the 
focus groups, interviews and town 
halls suggest that Americans are 
concerned that increased use of 
genetic testing could lead to a society 
in which there is an expectation 
that everyone could or should be 
“perfect” and where there is less 
tolerance for diversity, imperfections, 
diseases or disabilities.  
“Where is the point at which 
‘otherness’ becomes ‘disability?’”
participant in Kalamazoo town 
hall
Participants frequently referred 
to the fi lm Gattaca and the book 
A Brave New World as a portrayal 
of a possible abhorrent future 
Figure 6.1: Level of Concern about Social Implications
Source: 2004 Survey
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brought about by reproductive 
genetic technologies.  Th ey stated 
that the world would be a poorer 
place if diff erences and disabilities 
were eliminated.  Several told 
stories about the contributions that 
individuals with Down syndrome, 
cystic fi brosis and sickle cell anemia 
have made to their communities.  
“I know a ton of  Down syndrome 
children that I can’t even imagine 
this world without.  They’re just 
phenomenal children.”
female participant from mixed sex/
race focus group, Massachusetts
“Well, I think the negative 
implication [of  PGD] is that we 
become less tolerant of  people who 
are different and have disease…
And it creates a false expectation 
that we all can be perfect.”
PGD specialist (interview)
Many preimplantation genetic 
diagnosis (PGD) providers and 
patients felt strongly that fears that 
PGD will result in a society where 
everyone is selected based on their 
genetic makeup are overstated 
and belong in the realm of science 
fi ction.  PGD patients felt that these 
fears pale next to the immediate 
concerns felt by families dealing with 
a genetic disease.
“It’s not like we’re trying to create 
the supreme race here; we’re just 
trying to have healthy kids.”
father of  a child with genetic 
disease (interview)
Who Will Have Access? 
“[T]here may be a certain type of  
population who cannot afford 
[these technologies], so then you’re 
giving those with more money, more 
power to choose…”
participant from Jewish female 
focus group, Massachusetts
Cost and lack of insurance 
coverage were seen as major barriers 
to the use of reproductive genetic 
testing, particularly PGD.  Focus 
group participants tended to view 
advanced reproductive technology 
as “something for rich people.”  
According to survey data, 65 percent 
of Americans were concerned or 
very concerned that even if the 
use of genetic technology became 
widespread, some people would 
be unable to aff ord it (Figure 6.1). 
Inequities in access were of greater 
concern for older Americans and 
Democrats.  It was of less concern 
for young males, individuals with  
post-graduate degree, Whites, and 
Fundamentalist and Evangelical 
Christians.
Th is concern was shared by some 
health-care providers and many 
patients who were interviewed.  
Providers described repeated 
unsuccessful attempts to convince 
insurance companies to provide 
coverage for the costs of PGD.  
Th ey stated that PGD is so new 
that insurance companies do not 
understand the technology.  Th ey 
also expressed the belief that insurers 
tend to be very shortsighted in their 
fi nancial considerations and base 
coverage decisions on short rather 
than long-term savings.  Some 
interview respondents expressed 
the belief that insurers are under 
political pressure not to underwrite 
a technology that many see as 
controversial. 
Th e majority of primary care 
and PGD providers said they 
felt insurance should pay for 
reproductive genetic testing, but 
several voiced concern about the 
burden that could be placed on the 
health-care system if it were covered.  
Many qualifi ed their support for 
insurance coverage by saying that it 
should be reserved for cases in which 
it is being used to avoid a serious, 
early-onset disease. 
PGD patients were quite 
passionate in their arguments that 
reproductive genetic testing should 
be covered by health insurance.  
Th ey argued that, from a purely 
fi nancial standpoint, not covering 
reproductive genetic testing was 
irresponsible because the fi nancial 
costs of treating a child with a 
genetic disease are so high.  Th ey 
also stated that insurance coverage 
was needed so that everyone who 
could benefi t from the technology 
could aff ord it.  
“I think that this should be 
available to everybody.  I don’t 
think that insurance should make 
you suffer…I think that’s insane 
because what they paid for my 
son having been born with this 
[disease]…his fi rst two years of  life, 
he was hospitalized nine times.  He 
almost died a few times.  You know, 
they wouldn’t have had that cost if  
he had been born healthy…I don’t 
think they see the full picture.”
PGD patient (interview)
Focus group participants 
generally believed that carrier 
and prenatal testing should be 
widely available and covered by 
Social Implications
38 Reproductive Genetic Testing: What America Thinks
health insurance, but they were 
split over whether PGD should be 
covered by insurance.  While most 
empathized with families aff ected 
by genetic disease who want to have 
genetically-related, healthy children, 
many believed that people who want 
to use an expensive procedure like 
PGD that has such a high failure rate 
should bear the cost of it themselves.  
Expecting others to bear the cost 
was “selfi sh,” especially since couples 
have alternative paths to parenting 
like adoption. 
“[I]f  the insurance is paying for 
it, that means I’m paying for it 
ultimately, because they’ve got 
to recoup that $60, $80 grand 
somehow, and it’s going to affect 
my rates…that’s great if  they’ve 
got the inclination that that’s 
where they want to dedicate their 
resources, and their savings, and 
they really want children.  I think 
that’s a choice that should be made 
available.  But I don’t think the rest 
of  us should pay for it.”
participant from White male focus 
group, Colorado
Some members of the general 
public and some primary care 
providers were reluctant to endorse 
widespread use of reproductive 
genetic testing because they did 
not think it was the best use of 
scarce health-care resources.  A 
nurse midwife and a family practice 
physician stated that there were 
ethical implications to investing 
in PGD technology when so many 
people lack access to basic prenatal 
and other health-care.  
While cost was the primary 
access barrier raised  by focus 
group and town hall participants, 
they also expressed concern about 
additional barriers that might limit 
people’s access to the technology.  
Th ey mentioned that many of these 
technologies are so new that patients 
do not know to ask about them, 
and providers do not know enough 
to off er them or refer patients to 
appropriate specialists.  
“…who is even caring that we are 
getting educated about possibly 
testing a child for sickle cell, or 
spina bifi da…if  you are going to do 
it for one, do it for all, or don’t do 
it at all…I mean if  the doctor does 
not present this information to you, 
how do you know to ask?”
participant from Black female 
focus group, Tennessee  
Additionally, people may not be 
able to take advantage of testing if 
they live in geographic areas where 
there are no providers.  
Will Access Barriers Increase 
Class and Racial Disparities?
“I see a world where only poor 
people have diseases.”
participant from females with no 
children focus group, California
Americans are almost universally 
concerned that reproductive genetic 
technologies will only be accessible 
to the white and wealthy, leading 
to ever wider disparities in health.  
Th e public fears that unequal access 
to the technologies would enable 
those who can aff ord it even greater 
advantage because their off spring 
would be healthier or even 
(futuristically) smarter and stronger 
than those without fi nancial 
resources.  
“[I]t’s not the poor families in Africa 
that are going to be doing this, it’s 
going to be the very affl uent who 
are going to at fi rst have healthier 
children…and then it becomes 
the slippery slope, they will have 
stronger, faster, smarter children…
Then you’ve got these two very 
disparate classes.”
participant from White male focus 
group, Colorado
“[M]ost of  the Black community is 
not going to have access to this.”
participant from Black male focus 
group, Tennessee
“[T]he universe that I live in right 
now, it’s mostly rich, White, well-
educated humans who are utilizing 
assisted reproductive technologies.  
And so that has the potential 
to really create inequities or 
exacerbate inequities that already 
exist.”
PGD provider (interview)
Decreased Efforts to Find 
Treatments or Cures
 
Americans do not want genetic 
testing to become a substitute for 
continued research into cures for 
genetic disease.  Some participants 
in the focus groups and town halls 
expressed concern that if the use of 
reproductive genetic technologies 
becomes widespread, it could lead to 
decreased research and development 
of treatments for diseases that can be 
detected before birth and the birth 
avoided.  
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“There [would be] fewer people who 
are sick, but there’s less attention 
given to the sick people.  Like 
there’s less...priority given to those 
diseases.  I would want to make 
sure that, even though they’re a 
minority, that they’re still being 
taken care of  somehow.”
female participant from mixed sex/
race focus group, Massachusetts
Survey participants were asked 
how concerned they were that 
widespread use of genetic technology 
could result in decreased research 
to develop treatments for certain 
diseases, and 78 percent of surveyed 
Americans said they were concerned 
or very concerned about this 
possibility (Figure 6.1).  Women, 
Democrats and all Christians 
(compared to non Christians and 
those with no religious affi  liation) 
were more likely to be concerned 
about neglect of those with genetic 
disease.  Survey respondents of 
diff erent ages and races were equally 
likely to be concerned about this 
issue.
Will We Expect Perfect 
Children?
 “[C]hildren aren’t products, you 
know?”
participant from mixed sex/race 
focus group of  people over 55, 
California
Americans are enthusiastic about 
the possibility of using reproductive 
genetic testing to avoid genetic 
disease.  Additionally, a small 
minority of focus group participants 
thought that society would benefi t 
from using reproductive genetic 
testing to create smarter, stronger 
children.  
At the same time, the majority 
of Americans are concerned that 
increased use of this technology 
could change the way we think of 
children and increase the chances 
that we view them as commodities.  
Participants in the focus groups, 
interviews and town halls recognized 
that it is a natural inclination for 
parents to want to provide the best 
possible opportunities for their 
children.  Unfortunately, this drive 
may inevitably lead to competition 
to select for or against traits that may 
convey social advantage.  Th is may 
lead to unrealistic expectations of 
what it means to be a “perfect child.” 
 “We always want the best for our 
children.  But we always want the 
best children, too.” 
two Sacramento town hall 
participants 
“[S]ome people, they push their 
kid.  They want them to be the 
best…What if  we all want our kid 
more intelligent.  So your kid is 150 
[IQ]— I fi nd out, I want mine 180.  
Ech, no, don’t go there.  That’s too 
far.”
participant from Chinese American 
female focus group, California
“[I]t’s unfortunate, but there 
probably would be this whole 
competition thing… people perceive 
that if  you are more perfect or 
closer to perfection then you have 
more value as a human being.  I 
think that there are certainly 
negative social implications there.”
parent of  child with genetic 
disease (interview)
Participants in the focus group 
and town hall discussions were 
concerned that picking the genetic 
characteristics of one’s children 
would lead parents to put even more 
pressure on children to live up to 
unrealistic expectations.  Participants 
occasionally mentioned that dealing 
with disappointment from one’s 
children is part of parenting.  
 A town hall participant 
mentioned that with so much 
emphasis on genes, we may forget 
about the role nurturing plays in 
raising healthy, happy children.  
Other focus group and town hall 
participants feared that children 
selected to meet parents’ preferences 
would embody unhealthy prejudices 
and perpetuate them in future 
generations, further narrowing 
diversity and increasing ignorance 
about any other way to look or 
function.
“Kids come in all shapes and sizes.  
And some aren’t perfect.  And I 
think that they’re still valuable.”
female participant from mixed sex 
focus group, Massachusetts
  
Of survey respondents, 70 percent 
agreed or strongly agreed that 
they are concerned that the ability 
to control human reproduction 
will lead to treating children like 
products (Figure 6.2). 
Religion, income and education 
were associated with the degree 
to which Americans agree that 
the ability to control human 
reproduction will lead to treating 
children like products (Table 6.1).  
Eighty percent of Fundamentalist 
or Evangelical Christians agreed 
with this statement compared to 
only 61 percent of those who had no 
religious preference.  Of those with 
a post graduate degree, 55 percent 
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agreed compared to 73 percent 
without a college degree.  Th ose with 
less income were also more likely to 
agree with this statement.  
Conversely, participants in focus 
groups and town halls raised the 
concern that this technology could 
lead to a society in which children 
hold their parents accountable for 
their reproductive decisions.  
“As parents you would now be 
responsible for choices you made.  
There will be lifelong replaying of  
those choices.  Children would say 
‘why did you choose me to be like 
this, when you could have chosen 
me to be like that?’”
participant in Seattle town hall
Privacy of Genetic Information
“I think in another 20 years we’re 
going to have a bar code on our 
forehead, and they’re going to 
scan the damn thing and know 
everything about us.”
male participant from mixed sex/
race focus group of  people over 55, 
California
Americans see the potential for 
great benefi t from reproductive 
genetic testing, but they also 
want the opportunity to decline 
reproductive genetic testing and 
control how the information is 
used.  Th ey are concerned that test 
results might be used in ways that 
are harmful rather than helpful for 
individuals and families.  
Focus group, interview and town 
hall discussions demonstrate that 
people do not want to receive genetic 
testing without fi rst being informed 
that testing is optional and that it 
has implications beyond standard 
prenatal testing.  Th is appears to be a 
valid concern since several providers 
admitted in interviews that they 
or their colleagues did not obtain 
informed consent prior to ordering 
carrier testing and mentioned test 
results only if they were positive.  
Americans want limits on who 
has access to test results because they 
are concerned about how disclosure 
might negatively aff ect them and 
members of their families.  While 
over three-fourths of Americans 
surveyed in 2004 stated that the 
spouse of a person carrying a gene 
increasing the risk of disease has 
a right to know, and more than 
half stated that extended family 
members have a right to know, most 
oppose disclosing this information 
to an employer or health insurer. 
(Figure 6.3).  Over time, and as 
this issue has received more media 
attention, support for disclosure 
to a person’s employer or health 
insurer has declined, while support 
for disclosing to a person’s family 
members has increased (Figure 6.3).
People who are White, more 
educated and who do not have a 
religious affi  liation were more likely 
to say that others do not have a right 
to know their genetic information.
Qualitative data indicate that 
the public is concerned about what 
insurers and employers might do 
with information obtained from 
genetic tests.  Th e public is fearful 
that disclosure to employers could 
result in job loss or employment 
discrimination, and disclosure 
to insurers could result in being 
ineligible for or loss of both health 
and life insurance.
Figure 6.2: The Ability to Control Human Reproduction Will Lead to 
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“Will you have trouble getting a job 
because you have this gene that 
may cause cancer, whether or not 
you have cancer?”
Sacramento town hall participant
“If  insurers paid for tests, they 
would want to know the results and 
that could affect what they would 
be willing to cover.”
Fort Worth town hall participant
Will We be Able to Make Free 
Choices?
“You have to think about your 
health insurance…If  the insurance 
company paid for the test that said 
that the baby had cystic fi brosis, 
could they say “We’ll pay for an 
abortion, but we won’t pay for the 
child’s [health] care?”
male participant from mixed sex/
race focus group of  people over 55, 
California
Americans do not want families 
to be coerced into using reproductive 
genetic testing, and they especially 
do not want women to be pressured 
into aborting a fetus that has been 
diagnosed with a genetic disease.  
Focus group, interview and town hall 
participants were worried that social 
pressures, health-care providers and 
especially insurance policies have 
the power to create incentives to use 
the technology to prevent the birth 
of children that might be perceived 
to be a burden.  Th ey viewed such 
incentives as coercive.  For instance, 
they worried that insurers could 
Table 6.1: The Ability to Control Human Reproduction Will Lead 
to Treating Children Like Products.
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*** Other Christian includes all who self-identifi ed as Other Christian, excluding those that additionally self-identifi ed as Fundamentalist or Evangelical.
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require prenatal testing and, if a 
genetic disease was detected in a 
fetus, refuse to cover treatment 
for that specifi c genetic disease or 
raise the family’s premium.  Since 
treating genetic disease can be 
very expensive, families could feel 
coerced into having an abortion if 
they could not aff ord health-care 
for the resulting child.  Additionally, 
people fear that insurers could 
simply terminate a family’s policy if a 
genetic disease was detected. 
“Would insurance play into this?  
Are they going to limit me from 
further examinations?  Are they 
going to stop payment?  What is this 
going to do in the future?  Would I 
be considered high risk?”
adult with genetic disease 
(interview)
Widespread fear of being 
coerced into using the technology 
is evidenced by survey fi ndings.  
Th ree-fourths of Americans said 
that if the use of reproductive 
genetic technologies were to become 
more widespread, they would be 
concerned or very concerned that 
parents would be pressured to 
use this technology (Figure 6.1).  
Women, Whites and Republicans 
were slightly more concerned about 
parents being pressured to use this 
technology.  Fundamentalist and 
Evangelical Christians expressed 
more concern about this issue than 
all other religions.
Genocide 
“Taken in the wrong direction, this 
is a potential technology for an 
alternative to ethnic cleansing.”
participant in Seattle town hall
A less prevalent, but important, 
theme that emerged in focus group 
and town hall discussions was the 
fear that genetic testing and related 
technologies might be misused to 
attempt to create a “master race,” 
or worse, eliminate certain groups.  
Th ere were numerous references to 
Hitler and the eugenics movement 
as examples of the direction people 
feared.  Th ere was some concern that 
individual choices could result in 
large population changes  but what 
most concerned participants was the 
possibility of eugenics campaigns 
sponsored by governments.  
Concerns about governments using 
the technology for social engineering 
were great enough for some of 
these participants to argue that 
government should stay out of all 
reproductive decision making.
“What if  they all of  a sudden 
say, ‘hey, let’s just eliminate all 
Mexicans?’ —  [We’re] gone.” 
participant from Catholic Mexican 
American female focus group, 
California 
“…go back to Hitler, the Aryan 
race.  That was all that was 
supposed to survive in the world.  
Not one of  us in here is blonde 
haired, blue eyes and six feet tall.  
We wouldn’t be sitting here if  his 
mentality ruled.  So all I can see 
is that down the line we think it’s 
our choice, but eventually someone 
is going to take over, and there is 
going to be a power struggle and 
oh, let’s just recreate what race is 
supposed to look like.”
female participant from mixed sex/
race focus group, Massachusetts 
Figure 6.3: Genetic Privacy 
“If a genetic test shows that a person has an increased risk for a genetic disease, 
does the person’s ______ have the right to know?”
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“[V]ery rarely has the majority 
instituted anything into our 
community that created a positive 
effect.  This is dangerous.”
participant from Black male focus 
group, Tennessee
“Our society could step in, and 
if  the disease is in your family, 
they’ll say ‘no…you’re going to 
be sterilized.  You can no longer 
give birth, because you’re going to 
give birth to somebody who has a 
disease, and we don’t want disease 
in our society.’”
participant from male focus group, 
California
Overpopulation
“Well, you know, disease is also like 
a natural selective evolution, and 
we need that because what is going 
to happen a hundred years from 
now when there is no disease?  The 
world is going to be overpopulated.”
participant from Catholic Mexican 
American female focus group, 
California 
Additionally, a common point 
of discussion in focus groups was 
that disease is a necessary part of 
population control.  Th ere was 
a concern that the world would 
become overpopulated if genetic 
diseases were eradicated through 
reproductive genetic testing.  
“Then 200 years from now, a 
thousand years from now, there is 
a race of  perfect (people), and there 
are billions of  us, because we’re 
all perfect.  And I wish health for 
everybody of  course, but I don’t 
know if  having trillions and trillions 
of  people on the earth is going to be 
a good thing in the end.”
participant from young male focus 
group, Tennessee
Survey fi ndings confi rm that 
this is an important concern for 68 
percent of Americans (Figure 6.1).  
Young women, people with less 
formal education and Democrats 
tended to be more concerned 
about overpopulation while 
Fundamentalist and Evangelical 
Christians were less concerned when 
compared to other religious groups.  
In the interviews, health-care 
providers were less likely than focus 
group participants to express this 
fear and more likely to see genetic 
technologies as analogous to existing 
treatments for diseases.
Social Implications
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Americans want to be sure 
that reproductive genetic testing 
is safe — that it does not result in 
physical harm to the mother or 
resulting child — and that it actually 
provides accurate, clinically-relevant 
information.  People value accuracy 
because they understand that couples 
will make profound, life-altering 
decisions based on test results.
Most of the evidence that safety 
and accuracy of genetic testing are 
important to Americans comes 
from the focus group and town 
hall discussions.  Focus group 
participants were presented with 
hypothetical scenarios and asked 
what issues a couple should consider 
before using reproductive genetic 
testing.  Town hall participants 
were shown a background video on 
genetic testing and specifi cally asked 
to consider the issue of whether and 
how to regulate safety and accuracy 
of genetic testing.  
Th e importance of safety and 
accuracy of reproductive genetic 
testing was addressed in the 2004 
survey through questions about 
whether or not the government 
ought to regulate the quality and 
safety of reproductive genetic testing. 
Th ese data are presented in Chapter 
Eight.
Inaccurate Test Results Can 
Have Devastating Consequences
Participants in most of the focus 
groups brought up the importance 
of accuracy of reproductive genetic 
testing as a concern because the 
consequences of inaccurate test 
results — the transfer of an aff ected 
embryo, the abortion of a healthy 
fetus or, alternatively, the birth of 
an aff ected child — could be so 
devastating.  
“What is the reliability of  the results 
of  the  test?  Do they have a ninety-
fi ve percent, or higher, accuracy, or 
are they talking eighty percent, and 
there’s a wide range of  discrepancy.  
There could be a mistake.”
participant from Catholic White 
female focus group, Michigan
Town hall participants were 
asked specifi cally to think about 
and discuss this issue.  In every 
town hall, safety and accuracy of 
testing were listed as important 
factors to consider when setting 
limits on the use of reproductive 
genetic testing.  Participants in the 
town halls pointed out that it is 
impossible to make truly informed 
reproductive decisions without 
accurate information. Some town 
hall participants called for limits on 
direct-to-consumer marketing of 
genetic tests to reduce the amount of 
misinformation.
Several focus group participants 
cited the importance of test accuracy 
aft er sharing personal experiences 
about their own or other’s false-
positive prenatal screening tests.1  
  
“I have heard many stories from 
other moms, that they were told 
that their baby had a certain 
percentage to survive or to have 
this and then they decided to either 
terminate the pregnancy or keep 
it, and the baby is healthy, and the 
doctors were wrong.”
participant from Mexican 
American female group, California
Participants perceived the 
abortion of a wanted, healthy fetus 
based on a false-positive test result to 
be a horrendous outcome.  
Participants also occasionally 
expressed concern about false-
negative genetic test results, test 
results that indicate the absence of 
a gene mutation when in fact it is 
present, and the unexpected birth of 
an aff ected child.  
Parents of children with cystic 
fi brosis (CF) raised the possibility 
of false-negative test results with 
carrier testing since the standard 
CF test used in carrier testing does 
not cover all CF mutations.  Th ey 
said that providers need to discuss 
the possibility of false-negative test 
results with couples considering 
carrier testing.
People who had used 
preimplantation genetic diagnosis 
(PGD) believed they should have 
Chapter 7: Accuracy and Safety
“The availability of  testing should 
be as widespread as possible — but 
widespread testing without safety 
and accuracy, I can’t endorse.”
participant in Seattle town hall  
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asked more questions about the 
likelihood that misdiagnoses 
could be made.  Th ree PGD users 
experienced misidentifi cations in 
their PGD test results.  Although in 
two cases the misidentifi cations were 
not clinically signifi cant, they did 
cause the patients anxiety.  In one 
case, the interview participant was 
pregnant with a fetus aff ected by the 
disease she was trying to avoid by 
using PGD.  It was unclear whether 
this resulted from a misdiagnosis in 
PGD or a mix up in the embryos that 
were transferred.  
“And who does [PGD]?  It can be 
only in a few places around the 
world.  But do you have results on 
how these are turning out?  My 
feeling is, okay, there’s always a 
chance of  a mistake when they test 
these embryos.”
participant from Evangelical 
female focus group, Colorado 
Miscarriage is a Substantial Risk 
of Prenatal Testing
Most focus group participants 
perceived carrier testing to be 
safe since it is “just a blood test” 
similar to other routine blood tests 
during pregnancy.  Prenatal testing 
through CVS or amniocentesis was 
perceived to be more invasive, and 
some participants considered the 
risk of miscarriage unacceptable.  
A few parents of children with 
genetic diseases and all the women 
who became pregnant following 
PGD were especially wary of the 
miscarriage risk from invasive 
prenatal testing.  
“[W]e got scared about doing the 
CVS.  I mean we knew there was 
potential for miscarriage, and we 
had just gotten pregnant.  We didn’t 
want to lose this child.”
PGD patient (interview)
When considering whether or 
not using prenatal genetic testing is 
acceptable, focus group participants 
weighed the statistical risks of 
miscarriage against the perceived 
risk of having a child with a genetic 
disease.  Th ey also considered what 
they would do with the information.  
Some participants who would not 
consider abortion or would not 
want to be faced with the dilemma 
of whether or not to continue a 
pregnancy said they thought there 
was value in prenatal testing only if 
treatments were available that could 
be used before birth.   
Is PGD Harmful for Children?
“[Y]ou are guaranteeing that the kid 
won’t have sickle cell. But through 
[PGD] and all of  this manipulation, 
what other diseases or malfunctions 
or disfi gurements will this child 
have?”
participant from Black male focus 
group, Tennessee 
Many focus group and town hall 
participants were concerned about 
whether PGD has been adequately 
researched and is truly safe.  Some 
wondered if PGD could cause birth 
defects or other abnormalities 
and worried that there may be 
insuffi  cient knowledge about the 
dangers for the resulting child. 
“[They need to ask] what kind of  
side effects that procedure might 
have on the baby…will [PGD] affect 
it as it’s growing up? Look at Dolly 
that sheep that was cloned.  It 
grew up to have the worst kind of  
arthritis a sheep could have, and 
they ended up killing it.”
participant from White male focus 
group, California
Interview participants who 
had experience with PGD also 
questioned if it could lead to birth 
defects or long-term problems for 
the child related to the hormones 
given as a part of in vitro fertilization 
(IVF), the biopsy, the embryo culture 
or the transfer procedure.  Th ese 
interview participants also raised 
the issue of the increased likelihood 
of multiple births following IVF.  
Some focus group participants, 
PGD providers and PGD patients 
raised the concern that the PGD 
biopsy could result in embryo loss. 
One PGD patient said she harbored 
lasting concerns that the biopsy 
process would have long-term 
negative eff ects on her child.  
Providers were also concerned 
that, because PGD laboratories are 
not adequately regulated, not all 
providers who are off ering PGD have 
the expertise needed to perform the 
procedure safely and accurately.  
The Limited Effectiveness of IVF 
Even if PGD were completely safe 
and accurately identifi ed genetic 
alterations, a number of focus group 
participants stated that the chances 
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of having a live, healthy baby seemed 
too low to warrant the expense, 
discomfort, time and risks associated 
with PGD.  
PGD providers and patients who 
had undergone PGD focused heavily 
on the need for anyone considering 
using PGD to have realistic 
expectations of the technology to 
fully understand its limitations. Th ey 
felt couples need to know that the 
PGD process may result in only a 
very few or no viable embryos free 
of the disease-causing alteration, 
and that testing for one genetic 
disease does not guarantee that a 
baby will be born without genetic 
abnormalities.
“I think they really need to know 
the limitations - that this isn’t 
going to guarantee a healthy 
baby and that we’re not testing 
for everything. We can’t test for 
everything.”
Genetic Counselor (interview)
Several PGD patients said they 
felt they may have had too much 
faith in the technology when they 
started PGD.  Many reported feeling 
that they had been overly optimistic, 
both about the number of healthy 
embryos that would be available for 
transfer and about the likelihood 
that PGD would result in a viable 
pregnancy.  Because they were not 
infertile, they believed their chances 
of success with IVF would be greater 
than the statistics quoted by the 
clinics. 
“I think [what is important is] 
knowing the true success rates of  
IVF - how many embryos you’re 
likely to have - I think just the real 
stats.  I don’t feel that someone was 
trying to hide the stats; I just don’t 
think anyone worked really hard to 




1 Most women who relayed experiences 
with false positive test results were talking 
about maternal serum screening, which 
identifi es fetuses at higher risk for genetic 
and other anomalies but has a high false 
positive rate. Maternal serum screening is 
not diagnostic, and women with positive 
screening results are generally offered 
prenatal genetic testing to establish a 
diagnosis.
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Th e term “oversight” means 
diff erent things to diff erent people, 
and encompasses many diff erent 
approaches.  Deciding what kind of 
oversight might be appropriate or 
desirable for reproductive genetic 
testing requires consideration of 
several questions: What do we 
seek to prevent or, alternatively, to 
promote through regulation? What 
values do we wish to preserve? 
Whom are we trying to benefi t? And, 
perhaps most importantly, in whom 
do we want to place our trust to 
make these decisions?
Oversight of reproductive genetic 
testing could come from a variety 
of diff erent entities, working alone 
or in combination.  Th e federal 
government, state governments and 
scientifi c and medical societies are 
all potential sources of oversight.  
Insurance companies could also 
have a regulatory role through their 
reimbursement policies – lack of 
coverage for certain tests would 
likely deter many from using 
them, whereas providing coverage 
would likely lead to increased use.   
Decisions about reproductive genetic 
testing could continue to rest solely 
with patients, in consultation with 
their health-care providers.  Each 
of these oversight approaches has 
benefi ts and drawbacks. 
 
Th e Center’s accompanying 
report, Reproductive Genetic Testing: 
Issues and Options for Policymakers, 
addresses current oversight of 
reproductive genetic testing and 
presents a range of distinctly 
diff erent oversight options that 
could be adopted depending on 
one’s answers to the questions posed 
above.
Th is chapter discusses Americans’ 
opinions about the oversight 
of reproductive genetic testing, 
based on both our qualitative and 
quantitative studies.  Focus group 
participants were asked to discuss 
whether and how these technologies 
should be regulated.  Participants 
in the town halls discussed in detail 
whether these technologies ought to 
be regulated and were asked to react 
to a list of potential consequences 
of regulation. Survey respondents 
answered a series of questions about 
how to regulate prenatal genetic 
testing and preimplantation genetic 
diagnosis (PGD) as well as questions 
about their views of government 
regulation and personal liberty.  
Together, these data paint a detailed 
picture of the diverse views among 
the American public about the 
appropriate means of governing the 
development and use of reproductive 
genetic testing. 
Who Decides?
“It’s easy to say testing shouldn’t be 
used for this reason or that reason, 
but who will decide which purposes 
are OK?  A mother could say, ‘I want 
testing for disease,’ but actually be 
thinking ‘I don’t want another boy.’ 
Setting limits would be impossible. 
To fi nd out the real reasons would 
be a huge invasion of  privacy.”
Seattle town hall participant
In discussing the possible 
means of overseeing reproductive 
genetic testing, focus group, 
interview and town hall participants 
primarily discussed the proper 
balance between governmental 
involvement and individual and 
family decisionmaking.  Th ey 
identifi ed a number of diffi  culties 
the government might have in 
trying to regulate the appropriate 
use of these technologies.  First, 
many highlighted the diffi  culties in 
reaching consensus, in a pluralistic 
society, on ethically appropriate uses. 
Second, many felt that there were 
confl icting values and interests that 
would thwart eff orts to set limits.
“But I despair.  I don’t think that 
we have the will to limit what we 
unleash…The profi t motive is too 
strong.  And I think that we live in 
a society where people say that they 
deserve to have what they want.  
And I think that combination of  
profi t motive, and a feeling of  
entitlement means a society that 
will not agree on appropriate limits 
for this technology.”
mother of  three children with 
genetic disease (interview)
Th ird, many participants, 
especially women, feared that 
government limits on the use of 
reproductive genetic testing would 
eventually erode reproductive rights.  
Fourth, there was skepticism that 
laws could be enforced adequately 
because people could travel outside 
regulated areas and technology could 
go “underground.” 
“There is no way to avoid people 
abusing the advances.  That’s the 
problem.  And even if  there were 
laws and things like that, when 
there are people with money, 
anything can be done.”
participant from Jewish female 
focus group, Massachusetts
Finally, there was concern that 
politicians and legislators do not 
adequately understand reproductive 
genetic testing, which may lead to 
Chapter 8: Oversight of Reproductive Genetic 
Testing
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laws based on knowledge gaps and 
misperceptions.  In addition, they 
felt that the policymaking process 
itself is subject to pressure from 
those with particular agendas.  
“I don’t want people from any 
particular political administration 
to decide.”
Seattle town hall participant
A theme repeated across the focus 
groups and some interviews was 
that any governmental regulatory 
decisions about reproductive 
genetic testing ought to be made or 
informed by a diverse group that 
includes “average people,” regulators, 
policymakers, scientists, patients, 
families aff ected by genetic disease, 
health-care professionals and 
religious leaders.  Th is preference 
stemmed from a general lack of trust 
in politicians or scientists to make 
decisions that are in the best interest 
of the public.
“I think you should have some 
kind of  committee, like in a court.  
Like a jury.  Like…the American 
Medical Association has one 
person.  Somebody from the public, 
somebody from the state, somebody 
from everything… a panel.  And if  
they do not all agree, then it doesn’t 
go through.”
 participant from Mexican 
American male focus group, 
California
“I think that in a perfect world,…
majority rules.  Take a societal 
type of  survey, for lack of  better 
terminology.” 
 mother of  child with genetic 
disease (interview)
Some focus group participants 
were troubled by the practical 
diffi  culty of trying to regulate 
reproductive genetic testing based on 
moral considerations, while others 
argued that the government has no 
place regulating moral decisions that 
can have such a profound impact on 
individuals’ lives.  
“We have to depend on people’s 
morality to draw their own lines.  
We cannot legislate it…We can’t 
legislate any of  this stuff.” 
participant from White Protestant 
female focus group, Massachusetts
“Why would you want somebody 
else involved… what about your 
privacy?…You have to have the 
permission of  the government to 
do what you want to do with your 
sperm and egg?” 
participant from female with no 
children focus group, California
“[T]he individual is going to make 
that determination.  It all comes 
down to us.  It does not come down 
to the government; it does not come 
down to somebody else making the 
decision for us.”
participant from Mexican 
American male focus group, 
California
Many focus group participants 
made it clear that while they had 
concerns about the development 
and use of these tests, they were also 
uncomfortable with the notion of 
the government imposing a single 
view on everybody.  Th e belief 
that moral decisions need to be 
left  to individuals rather than the 
government crossed all races, ages, 
education levels and religions.
Similarly, when given a choice of 
who should set limits (professional 
medical societies, individuals, 
government or patient groups), 
aft er discussion and debate, a third 
of town hall participants said these 
decisions should be left  to individual 
patients and their doctors.
A series of questions in the 2004 
survey further explored this tension.  
A majority of survey respondents 
agreed or strongly agreed with the 
statements: “I am concerned about 
unregulated reproductive genetic 
technology getting out of control” 
(84 percent) and “I am concerned 
about government regulators 
invading private reproductive 
decisions” (70 percent).  At the same 
time, a majority of respondents  (67 
percent) agreed or strongly agreed 
with the statement “We ought to let 
people decide for themselves when 
it is appropriate to use reproductive 
genetic technologies because the 
consequences are so personal” 
(Figure 8.1).
Survey respondents’ views about 
respect for personal autonomy 
– meaning letting people decide 
for themselves – were consistent 
with their views about regulating 
reproductive genetic testing.  
For example, those who did not 
support any regulation of PGD or 
wanted regulation based only on 
considerations of safety and quality 
of testing placed the most emphasis 
on personal autonomy (82 percent 
of those who favored no regulation 
or regulation of only safety and 
quality agreed with the statement 
that people should decide for 
themselves).  Th ose who wanted to 
ban the technologies placed the
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least emphasis on personal 
autonomy (only 40 percent of 
those who favored banning PGD 
agreed that people should decide for 
themselves).  Th ose who wanted to 
regulate based on ethics and morality 
fell in the middle with 63 percent 
agreeing that people should decide 
for themselves. 
Alternative Ways to Limit Use
Focus group participants 
discussed two alternative ways to 
limit the use of reproductive genetic 
technologies that did not involve 
government regulation.  Th ese 
included using health insurance 
coverage policies and limit-setting by 
health-care providers.
Focus group discussions about 
insurance company coverage policies 
typically centered on the fact that 
they might present a barrier to 
access to genetic testing technology 
if the costs were not reimbursed.  
Occasionally, however, participants 
mentioned that insurers’ coverage 
policies might serve to limit 
inappropriate uses of the technology 
by reimbursing only for appropriate 
uses. 
“I just think it is inevitable that we 
come down to who can pay for it, 
or can get their health insurance 
to pay for it.  So, I can see it being 
regulated by the health insurance 
companies being willing to cover 
certain diseases.” 
participant from female 
Evangelical focus group, Colorado
“Insurance determines what is going 
to be done.  The insurance company 
says, ‘well, you can have this done 
for this, but not for this.’”
participant from female Catholic 
focus group, Michigan
Occasionally focus group and 
interview participants, particularly 
parents of children with a genetic 
disease, suggested that physicians 
and professional societies should 
put limits on when and how they 
themselves market and provide this 
technology.  
“I think you set procedures, you 
set guidelines for it and these 
specialists…hopefully can tell if  
the person is doing this for the right 
reasons, and keeping them within 
that guideline, and making them 
understand that you aren’t going to 
have a perfect child, where you’re 
just going to try to take care of  this 
life-threatening disease, and you 
don’t get to pick and choose the eye 
color.”  
participant from Chinese American 
female focus group, California
“I think that there should be limits, 
and I don’t think that somebody 
should say they want to go have 
PGD because they have enough 
money to do it, and they want 
to have a girl.  I think that there 
should be a doctor that says, ‘I can’t 
do that for you.’” 
mother of  child with genetic 
disease (interview) 
Town hall participants discussed 
and debated who ought to set limits 
(medical professional societies, 
individuals, government or patient 
groups) and one-third chose medical 
professional societies as the best 
group to set limits.
However, some focus group 
participants were skeptical that 
medical professionals could police 
themselves, and said that there 
would still be unethical individuals 
willing to violate professional 
standards.  
Oversight
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“And, that’s where I start worrying.  
Because some doctors when you say, 
‘That’s not what the test is for.  I’ll 
[only] tell you if  your kid is going to 
be healthy or not.’  But again, there 
are some doctors out there who will 
be shady and will say, ‘Look, you 
can have the short kid or you can 
have the tall kid.  Which one do you 
want?’” 
participant from Black male focus 
group, Massachusetts
In fact, PGD providers saw more 
benefi t in expanding the uses of 
PGD than other respondents in the 
studies.  Th ose interviewed were 
loath to be regulated by government, 
yet admitted that their fi eld did have 
the potential to advance rapidly 
and without limits.  Some were 
already making decisions about the 
circumstances under which they 
were willing to provide testing.  For 
example, one PGD provider said he 
refused requests to test embryos for 
sex because of his personal morals, 
even though there are no state or 
federal regulations guiding his 
decision.  
Attitudes About Government 
Oversight
Th e level of support for or 
opposition to government oversight 
of reproductive genetic testing 
was further explored in the 2004 
survey (Figure 8.2, Tables 8.1 and 
8.2).  Survey respondents who 
disapproved of all proposed uses 
of prenatal genetic testing or PGD  
(see Chapter 3) were asked if they 
thought prenatal genetic testing or 
PGD should be allowed at all.  If 
they said no, they are represented 
in this report as supporting a ban 
on testing.  Respondents who 
approved of one or more uses of 
prenatal genetic testing or PGD and 
those who disapproved, yet said it 
should be allowed, were asked if 
the tests should be regulated by the 
government based on both quality 
and safety, and if the tests should be 
regulated by the government based 
on ethics and morality.  Th ose who 
responded no to both questions 
about possible roles for government 
regulation are represented as 
favoring no government regulation.    
Banning Reproductive Genetic 
Testing
Twenty percent of survey 
respondents said that PGD should 
not be permitted, and 11 percent 
said that prenatal genetic testing 
should not be permitted (Figure 
8.2).  Nearly three times as many 
Fundamentalist and Evangelical 
Christians supported a ban on 
prenatal genetic testing and PGD 
compared to those with no religious 
affi  liation.  Republicans and those 
in lower education groups were 
also more likely than Democrats 
and those with a college education 
to support banning both prenatal 
genetic testing and PGD (Tables 8.1 
and 8.2).
Ensuring Safety and Accuracy
In 2002, only 30 percent of survey 
respondents knew that the federal 
government does not review and 
approve reproductive genetic tests to 
ensure that they are safe and accurate 
before they are put on the market.  
In-person town hall participants 
were asked “as far as you know, does 
the government review and approve 
reproductive genetic tests to ensure 
that they are safe and accurate before 
they are put on the market.” Half 
(46 percent) thought, incorrectly, 
that the government reviews and 
approves tests while the other half 
(55 percent) responded correctly 
that the government does not 
currently play this role in oversight 
of reproductive genetic testing.  
A majority of respondents in 
the 2004 survey agreed that the 
safety and quality of PGD and 
prenatal genetic testing should 
be regulated (61 percent and 67 
percent, respectively).  Th irty-seven 
percent agreed that PGD should be 
Source: 2004 Survey




















Reproductive Genetic Testing: What America Thinks 53
additionally regulated for ethics and 
morality, while 40 percent stated the 
same for prenatal genetic testing.  
Interestingly, a greater number of 
young adults (66 percent and 77 
percent, respectively) agreed that 
both PGD and prenatal genetic 
testing should be regulated for 
safety.  Among religious groups, 
Fundamentalist and Evangelicals 
Christians were the least likely to 
support government regulation 
of safety and quality; however, 
this is likely due to the fact that a 
signifi cant proportion of this group 
preferred to ban PGD and prenatal 
genetic testing.  As level of education 
increased, so did the number of 
respondents who endorsed safety 
regulation, although the majority 
within each educational group 
supported regulation based on safety 
and quality.  More Democrats than 
Republicans supported government 
regulation of safety for both PGD 
and prenatal genetic testing, 
although a majority in both groups 
supported regulation based on safety 
and quality (Tables 8.1 and 8.2).
Even though there was strong 
support for regulation of safety, 
some recognized that such oversight 
could have a downside. Town hall 
participants were given a list of 
potential negative consequences of 
additional government regulation 
and asked how concerned they were 
about each.  Delaying access to tests 
and increasing the cost of tests was 
of concern to about half of town hall 
participants.  Fewer were concerned 
that regulation would be a burden 
to the biotechnology and laboratory 
testing industries or might not be 
eff ective in ensuring safety.
Ethics and Morality
Th irty-eight percent of the 
2004 survey respondents said the 
government should regulate PGD 
based on ethics and morality, 
while 43 percent said that the 
government should regulate prenatal 
genetic testing based on ethics and 
morality (Tables 8.1 and 8.2, sum of 
respondents who support regulation 
based on ethics and morality alone 
and those who supported regulation 
based on ethics and morality and 
safety and quality).  Just over one 
percent stated that government 
should regulate based on ethics only.  
Th e defi nition of “ethics and 
morality” was left  to the survey 
respondent to defi ne.  Focus group 
data indicated that people had a 
broad range of ideas about what 
regulation of “ethics and morality” 
actually means; therefore, it is likely 
that these numerical data do not 
represent a uniform group.  Instead, 
those who support regulation of 
ethics and morality likely represent a 
broad spectrum of values.
Approval for regulating both PGD 
and prenatal genetic testing based 
on ethics and morality was highest 
among younger respondents, males 
and Evangelical or Fundamentalist 
Christians (Figure 8.3, Tables 8.1 and 
8.2).  Minorities were also slightly 
more supportive of regulating these 
technologies based on ethics and 
morality than Whites.  No notable 
diff erences by political affi  liation, 
education level, or sex were 
observed.
No Regulation
A minority of survey respondents 
said that the government should not 
regulate reproductive genetic testing 
based on safety and quality or based 
on ethics and morality.  Overall, 17 
percent of survey participants did 
not want the government to regulate 
PGD and 19 percent did not want 
the government to regulate prenatal 
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testing.  Proportionally, more 
Whites, people over age 50, those 
with less education and Republicans 
agreed that these technologies 
should not be regulated at all (Tables 
8.1 and 8.2).
Other Possible Roles for the 
Government
Discussions in focus groups 
and town halls identifi ed areas in 
which some people thought the 
government could play a role in 
overseeing or tracking the eff ects of 
using reproductive genetic testing.  
Th ese themes included: 
•  Tracking the diff erent ways people  
are using these technologies
•  Studying the long-term eff ects of 
these technologies on women and 
children
•  Ensuring that people have equal 
access
•  Tracking populations eff ects like 
changes in the sex ratio
•  Funding genetic testing research
Th ese themes were tested 
among survey respondents.  A 
large majority of respondents (76 
percent) said they think tracking 
the ways in which genetic testing 
technologies are being used is an 
appropriate role for the government 
(Figure 8.4).  Nearly three-quarters 
also said that the government 
ought to be studying the long-term 
health eff ects of technologies like 
PGD on women and children.  A 
slimmer majority (58 percent) 
said that the government ought 
to ensure that people have equal 
access to these technologies.  
In focus group and town hall 
discussions, participants suggested 
that the government could ensure 
greater access through insurance 
mandates for private insurers and 
by including reproductive genetic 
testing in publicly-fi nanced health-
care programs.  Although a slim 
majority (55 percent) still supports 
the government tracking population 
eff ects such as changes in the sex 
ratio, support for this role is not as 
strong as the mandate to track the 
ways the technologies are being 
used and the health outcomes.  A 
number of focus group participants 
said that if there were demonstrable 
harmful populations eff ects, the 
government would have a more 
legitimate argument for setting limits 
on the use of reproductive genetic 
testing.  Americans are divided about 
whether they want their tax dollars 
to fund research on reproductive 
genetic testing.
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Oversight
Table 8.1: Opinion on Regulation of PGD by Demographic Characteristics (%)













 Total 20.3 16.9 1.4 37.0 24.3 61.3
Sex
 
Men 19.5 16.6 2.0 37.4 24.4 61.8
Women 21.0 17.2 0.8 36.7 24.2 60.9
Age
 
18-29 21.2 11.0 1.4 42.7 23.5 66.2
30-49 19.6 13.7 0.8 39.6 26.2 65.8




White 19.7 17.6 1.2 35.7 25.6 61.3
Black 21.9 13.8 1.7 40.6 22.0 62.6
Hispanic 20.1 16.9 2.3 40.5 20.2 60.7
Religion
 
Protestant* 15.3 19.2 1.8 36.5 27.2 63.7
Fund/Evang** 35.6 15.5 1.0 37.0 11.0 48.0
Catholic 20.3 15.9 1.9 39.5 22.3 61.8
Other Christian*** 20.5 15.9 1.0 39.0 23.5 62.5
Other (Non Christian) 16.4 14.3 0.9 38.5 29.8 68.3
No Religion 12.5 16.6 1.0 33.3 36.6 69.9
Income
 
Under 25k 19.1 18.7 1.8 37.2 23.2 60.4
25k-49k 22.3 17.4 1.0 37.0 22.4 59.4
50k-74.9k 22.9 14.5 1.3 34.0 27.2 61.2
75+k 15.2 15.1 1.5 41.0 27.4 68.4
Education
 
No College 23.7 18.8 1.6 36.2 19.7 55.9
Some College 19.1 17.5 1.3 37.0 25.1 62.1
College 15.9 12.6 1.2 38.5 31.8 70.3




Republicans 26.7 20.9 1.4 32.5 18.4 50.9
Other 22.2 17.4 1.2 40.0 19.2 59.2
Democrats 17.0 16.9 1.6 35.3 29.3 64.6
Source: 2004 Survey
* Protestant includes respondents who self-identifi ed as Protestant, excluding those who additionally self-identifi ed as Fundamentalist or Evangelical.
** Fundamentalist/Evangelical includes all Protestant or Other Christian respondents who additionally self-identifi ed as either Fundamentalist or Evangelical.
*** Other Christian includes all who self-identifi ed as Other Christian, excluding those that additionally self-identifi ed as Fundamentalist or Evangelical.
Table based on responses to three questions.  
(1) Should PGD be allowed at all?
(2) Do you think the government should regulate PGD based on quality and safety?
(3) Do you think the government should regulate PGD based on ethics and morality?
Ban=percent who responded ‘no’ to (1)
No regulation=percent who responded ‘no’ to (2) and (3)
Regulate ethics only=percent who responded ‘no’ to (2) and ‘yes’ to (3)
Regulate safety only=percent who responded ‘yes’ to (2) and ‘no’ to (3)
Regulate safety and ethics=percent who responded ‘yes’ to (2) and (3)
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Table 8.2: Opinion on Regulation of Prenatal Genetic Testing by Demographic Characteristics (%)













Total 11.0 19.3 2.4 40.3 26.9 67.2
Sex
 
Men 11.4 17.9 2.6 40.7 27.3 68.0
Women 10.6 20.6 2.3 40.0 26.6 66.6
Age
 
18-29 10.5 10.4 1.9 48.2 28.9 77.1
30-49 10.9 16.1 2.3 42.8 27.8 70.6




White 9.9 20.4 2.3 39.3 28.0 67.3
Black 11.6 15.5 2.1 44.5 26.3 70.8
Hispanic 12.4 18.8 4.2 41.2 23.4 64.6
Religion
 
Protestant* 7.6 21.0 2.5 39.9 29.0 68.9
Fund/Evang** 19.7 19.1 3.1 44.0 14.1 58.1
Catholic 10.1 19.1 3.2 42.0 25.5 67.5
Other Christian*** 13.9 17.7 1.1 45.0 22.3 67.3
Other (Non Christian) 7.5 14.8 1.8 38.4 37.4 75.8
No Religion 7.0 18.4 1.9 31.7 41.0 72.7
Income
 
Under 25k 11.5 19.5 2.6 42.2 24.1 66.3
25k-49k 11.5 20.8 2.2 39.3 26.0 65.3
50k-74.9k 11.4 18.0 2.6 37.4 30.6 68.0
75+k 8.5 16.8 2.3 42.0 30.3 72.3
Education
 
No College 13.6 21.6 2.2 40.3 22.3 62.6
Some College 10.3 19.4 2.7 39.7 27.8 67.5
College 7.4 14.4 2.8 41.0 34.4 75.4




Republicans 14.6 23.7 2.5 37.9 21.3 59.2
Other 15.0 20.0 2.5 41.0 21.4 62.4
Democrats 9.4 18.7 3.0 37.4 31.5 68.9
Source: 2004 Survey
* Protestant includes respondents who self-identifi ed as Protestant, excluding those who additionally self-identifi ed as Fundamentalist or Evangelical.
** Fundamentalist/Evangelical includes all Protestant or Other Christian respondents who additionally self-identifi ed as either Fundamentalist or Evangelical.
*** Other Christian includes all who self-identifi ed as Other Christian, excluding those that additionally self-identifi ed as Fundamentalist or Evangelical.
Table based on responses to three questions.  
(1) Should prenatal genetic testing be allowed at all?
(2) Do you think the government should regulate prenatal genetic testing based on quality and safety?
(3) Do you think the government should regulate prenatal genetic testing based on ethics and morality?
Ban=percent who responded ‘no’ to (1)
No regulation=percent who responded ‘no’ to (2) and (3)
Regulate ethics only=percent who responded ‘no’ to (2) and ‘yes’ to (3)
Regulate safety only=percent who responded ‘yes’ to (2) and ‘no’ to (3)
Regulate safety and ethics=percent who responded ‘yes’ to (2) and (3)
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As human genetics and 
reproductive medicine advance and 
move from the laboratory into the 
clinic, people will increasingly face 
decisions about what tests to have 
and what to do with the results.  
Reproductive genetic testing has the 
potential to change whether and how 
we have babies and, indeed, what 
kind of babies we have.  Technologies 
that have the power to aff ect the 
most profound and meaningful of 
human activities can bring enormous 
hope, and deep concern.  As the 
number and type of reproductive 
genetic tests increases, how are we 
as a society to ensure that their 
development and use is in keeping 
with our most deeply held values?   
Th e public debate about these 
and other reproductive genetic 
technologies over the last half-
century has suggested deep cleavages 
within American society mostly 
having to do with divergent views 
of the moral status of embryos and 
fetuses.  Some have concluded that 
these diff erences are irreconcilable.  
Yet, a detailed, textured portrait of 
what Americans know, think and feel 
has been missing.  
Th is report has presented 
the summary fi ndings from 
Th e Genetics & Public Policy 
Center’s eff ort to fully capture and 
understand American opinions 
about the appropriate uses of 
reproductive genetic testing and 
their thoughts about regulating this 
technology.  Th is study, the largest 
ever on this topic, incorporated 
both qualitative and quantitative 
approaches and included 21 focus 
groups, 62 in-depth interviews, two 
surveys with a combined sample size 
of over 6000 people, and both in-
person and online town halls.  
Th ese data on the way Americans 
think about these issues demonstrate 
that there is signifi cant agreement 
about some issues and incredible 
diversity about others.  Deeply held 
and sometimes confl icting values, 
such as 1) preventing suff ering, 
2) living one’s life in accordance 
with God’s will, 3) respecting 
nature, 4) promoting social justice, 
5) protecting individual privacy 
and autonomy, 6) respecting and 
protecting embryos and fetuses, and 
7) limiting the reach of government 
– color and shape individual’s views 
on these technologies and their 
oversight.  
Th e specter of unchecked 
advances raises many fears, such 
as designer babies, eugenics and 
genetically modifi ed human beings.  
Th ese values and fears converge, and 
sometimes confl ict, as Americans 
balance the potential benefi ts 
of advances in genetics with the 
possible negative consequences of 
their use.
When Americans think about 
the moral appropriateness of using 
reproductive genetic testing, they 
consider the individual’s motives 
— what does the user hope to 
accomplish and is this an appropriate 
use of the technology.  Th ey also 
consider the means — the safety 
of the technology, the available 
alternatives and whether or not 
embryos or fetuses will be destroyed 
in the process.  Th ey also want to 
know about the overall consequences 
- what will be the long-term 
implications for the health of 
individuals who use the technology, 
and how will widespread use aff ect 
society?   
When Americans who 
participated in our studies evaluated 
possible uses of reproductive 
genetic testing, there was signifi cant 
concordance of opinion at the 
ends of the spectrum of uses.  A 
majority of surveyed Americans 
think it is appropriate to use 
reproductive genetic testing to 
avoid life-threatening diseases that 
aff ect children or to test embryos to 
determine whether they will have 
tissue that matches a sick sibling.  
Many study participants value 
preventing the suff ering of a child 
above all, and some even perceive it 
to be an obligation.  For a minority 
of surveyed Americans, suff ering is a 
part of what makes us human and we 
need not use technology to avoid it.  
At the other end of the use 
spectrum, most surveyed Americans 
think that using (hypothetical) 
genetic tests to identify and 
select traits like intelligence and 
strength would be inappropriate.  
Interestingly, however, one-quarter 
of surveyed Americans think it is 
appropriate to use genetic testing 
(both PGD to select embryos and 
prenatal testing to identify whether a 
fetus has certain desirable traits) for 
these purposes.
Our research indicates that 
Americans are divided about the 
use of reproductive genetic testing 
to avoid adult-onset diseases.  For 
some, using these technologies to 
prevent diseases and conditions 
that many fi nd burdensome is 
comparable to early-prevention 
programs.  For others, there is deep 
concern that if we accept the use of 
Chapter 9: Conclusion
Converging and Confl icting Values
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these technologies for less urgent or 
compelling reasons, it will lead down 
the slippery slope to even more 
capricious use.  
While a majority of participants 
in our study objected to using 
hypothetical genetics test to identify 
non-disease related traits such as 
intelligence or strength, a substantial 
number approved of using PGD 
to select for sex.  In focus group 
discussion, some participants stated 
that sex selection through PGD is 
simply a more eff ective means of 
doing what couples have tried to do 
for centuries and were unconcerned 
about possible population eff ects 
since they felt that the preference 
for male children that exists in other 
countries is not present in the U.S..  
Some focus group and interview 
participants even think that use 
of sex selection methods could 
be advantageous to both families 
and their child.  Finally, some said  
through PGD might avoid the 
abortion of fetuses perceived to be 
the wrong sex.  
When evaluating the 
appropriateness of reproductive 
genetic testing, Americans also 
consider the means, or what actually 
has to physically happen in order to 
reach the desired outcome.  Having 
children that are free from genetic 
disease may be a laudable goal, 
but, for some Americans, using 
reproductive genetic testing to 
reach this goal is troubling.  Many 
Americans who participated in focus 
group discussions are concerned 
about the known and unknown risks 
to women and resulting children.  
Th ey also question why people who 
want to be parents would choose 
PGD when alternative paths to 
parenthood, such as adoption, are 
less expensive, more eff ective, and 
have less ethical baggage.  For many 
Americans, using reproductive 
genetic testing in order to make 
decisions about who is fi t to come 
into the world amounts to playing 
God, particularly if embryos and 
fetuses are destroyed in the process. 
Finally, Americans are concerned 
about the ultimate consequences 
of widespread use of reproductive 
genetic testing.  Th ey fear a world in 
which children are expected to be 
perfect, and parents are expected to 
do everything possible to prevent 
children with genetic disease 
from being born.  How might this 
aff ect the way we treat and care for 
those with disabilities?  Because 
this technology is expensive and 
frequently not covered by health 
insurance, could its use result 
in greater health and economic 
disparities?    Many of these fears are 
not unique to reproductive genetic 
testing.  Th ey echo deep concerns 
about how many advances in 
technology challenge the values that 
our society holds sacred.    
Th e majority of surveyed 
Americans wants and expects 
oversight to ensure safety, accuracy 
and quality of reproductive genetic 
testing.  Depending upon how the 
questions are asked, Americans both 
support and resist governmental 
limits based on ethics and morality.  
When Americans are asked 
about regulating each individual 
technology, one-third of respondents 
favor limits based on “ethics and 
morality.”  Twenty percent and 
11 percent favor a complete ban 
on PGD and prenatal testing, 
respectively; when respondents were 
asked whether they are concerned 
about government regulators 
invading private reproductive 
decisions, however, 70 percent 
said they were concerned or very 
concerned.  Wanting to have it 
both ways actually mirrors the 
ambivalence witnessed during 
the focus group and town hall 
discussions, and may also refl ect 
variation in what people are thinking 
about when they speak of “ethics 
and morality.”  Just under a fi ft h 
of all Americans think that the 
government should avoid regulating 
genetic testing completely.  For 
a portion of these Americans, 
this discomfort with government 
regulation is so deeply held that 
they resist government regulation in 
spite of their concerns about these 
technologies.  
Th e Americans that participated 
in the focus groups, interviews, and 
town halls were deeply interested 
and engaged in discussions about 
the appropriate use and regulation of 
reproductive genetic testing.  Th ey 
held sophisticated and nuanced 
discussions that mirrored those 
occurring in academic circles.  
Th e analyses in this report 
represent the fi rst look at the rich 
and textured data obtained from 
the opinion research conducted 
over the last two years. Th e Center 
looks forward to more in-depth 
analysis of these data to contribute 
to the public dialogue and to inform 
the development of policies to 
govern the development and use of 
reproductive genetic tests.
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A team of researchers designed, 
implemented, and analyzed the 
qualitative research (Table 1).   Th e 
study populations included:  (1) 
members of the general public, most 
of whom had little experience with 
genetic technologies, and (2) key 
informants who had more experience 
with genetic technologies, including 
families aff ected by genetic diseases, 
people who have experience with 
PGD and health-care providers.  Data 
were collected from the general public 
through focus groups and from the 
remaining study populations through 
in-depth interviews.  
All focus groups and interviews 
were audio taped and transcribed.  
Th e transcripts were then imported 
into NVivo, a qualitative data 
management and analysis soft ware 
program.  Data were coded to enable analysis of themes that emerged from the data.  
Th e study instruments and informed consent protocol were reviewed and approved by the Institutional Review 
Boards at Johns Hopkins University, Abt Associates Inc., and the University of Pennsylvania.
Focus Groups
Twenty-one, two-hour focus groups were conducted with 181 members of the general public (8.6 people per 
group on average) between March 31 and April 22, 2003.  Focus groups were conducted in cities located in fi ve states 
(Massachusetts, Tennessee, California, Colorado, and Michigan) representing major U.S. geographic regions.
A national focus group vendor provided facilities, recruited participants from their existing database of potential 
focus group participants and collected minimal demographic data.  People included in these databases have volunteered 
to participate in focus group research.  Th ey were recruited by word of mouth, telephone and the Internet.  People were 
eligible to participate if they were fl uent in English and had not participated in a focus group within the last 6 months.  
Participants received $75 for their time.  To ensure that a broad range of perspectives were solicited and the discussions 
in each group were rich and nuanced, participants were grouped in terms of gender, age, race/ethnicity, religion, 
parental status and education.  Th ese demographic characteristics were selected because they had been shown to be 
associated with people’s attitudes toward genetic technologies in the national telephone survey conducted by the Center 
in 2002.  Th e characteristics of each focus group are shown in Table 2. 
An experienced moderator facilitated each focus group using a discussion guide.  Th e guide consisted of a series of 
scenarios – realistic situations confronting fi ctitious couples involving choices about reproductive genetic technologies 
that might occur now or in the future – and included questions to get participants to react to the situations.  Each 
scenario built on the technical information presented in the previous scenario(s).  Scenarios fi rst presented participants 
with the situations and technologies they were most likely to be familiar with and progressed to increasingly complex 
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Table 2: Focus Group Characteristics
Group No.
No. of 
People Location Sex Age Parent?
Race/ 
Ethnicity Religion Education
1 8 Massachusetts Mixed 25-40
2 7 Massachusetts Female 35-45 Jewish
3 5 Massachusetts Female 25-34 Mexican-
American
4 7 Massachusetts Mixed 25-34
5 9 Massachusetts Male 25-34 Black
6 6 Massachusetts Female 25-45 Protestant
7 9 Tennessee Female 25-34 Black College 
degree or >
8 9 Tennessee Male 35-45 Black
9 8 Tennessee Male 18-25 No
10 10 California Female 35-45 No
11 7 California Female 35-45 Mexican-
American
12 9 California Male 35-45 Mexican-
American
13 9 California Male 35-45 < or = a 
high school 
diploma 
14 9 California Mixed 55+ Yes
15 7 California Female 25-45 Chinese-
American
16 11 Colorado Female 25-34 Evangelical
17 11 Colorado Female 18-25 No
18 8 Colorado Male 25-34 White College 
degree or > 
19 10 Michigan Female 35-45 White < or = a 
high school 
diploma 
20 11 Michigan Female 35-45 Black < or = a 
high school 
diploma 
21 11 Michigan Female 25-34 White Catholic
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and/or futuristic stories (Table 3). Th ey also began with the use of reproductive genetic testing for serious, potentially 
fatal disease, then moving on to consider less serious, non-fatal health conditions, and fi nally asked participants to 
consider trait selection.  Th e last section of the guide asked participants to refl ect back on the technologies that had been 
discussed and consider the social, regulatory, scientifi c, and ethical implications of the technologies.  
Focus group moderators were assigned to groups according to their own personal characteristics to maximize 
cultural appropriateness whenever possible.  Center staff  trained the moderators on genetic concepts related to the 
technologies in the discussion guide.  A focus group methods report is available at www.DNApolicy.org.
Interviews
In-depth interviews were conducted with 62 individuals including families 
aff ected by genetic diseases, people who had used PGD, and health-care 
providers between July 24, 2003 and March 4, 2004.  Interviews were conducted 
over the telephone and lasted between 60 and 120 minutes (90 minutes on 
average).  To ensure that participants with a broad range of perspectives 
on reproductive genetics were included, 12 types of families and providers 
were recruited (Table 4).  Th e genetic diseases were chosen in part based on 
convenience sampling but also to ensure that the diseases were moderate to 
severe and not limited to a single racial/ethnic group.
Potential interview respondents were recruited primarily using the Internet 
beginning in July 2003 and ending in March 2004.  All of the adults with a 
genetic condition had either achondroplasia or Marfan syndrome and were 
recruited via their providers.  Parents of children with a genetic condition were 
recruited through a cystic fi brosis organization.  PGD patients were recruited 
through either PGD providers or advocacy organizations’ listservs (the cystic 
fi brosis and Fanconi anemia organizations).  Other conditions represented 
by the PGD patient interviewees included Fabry disease, hemophilia, and 
congenital adrenal hyperplasia.  PGD specialists were identifi ed by the Genetics 
and Public Policy Center and recruited directly.
Th e research team developed separate interview guides for each group.  Each guide consisted of a core set of questions 
based on scenarios from the focus group moderator’s guide as well as questions specifi c to their personal experience or 
clinical practices. 
Individuals fi rst received a recruitment letter and a disclosure statement describing the study and eligibility criteria (such 
as fl uency in English and recruitment criteria specifi c to each group).  It directed interested potential interviewees to call 
a toll-free study hotline to fi nd out more information about the study and to schedule an interview.  
Interviews were conducted by one of three experienced interviewers who were trained in basic genetic concepts by 
Center staff .  Limited demographic data were also collected.  All groups except the PGD providers (PGD specialists, 
PGD nurses and assisted reproductive technology genetic counselors), received a $50 token payment for their time.  
PGD providers were not off ered a monetary incentive because we assumed that they would be willing to discuss 
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Table 3: Focus Group Scenario 
Progression
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Table 4: Recruitment Sources and Criteria for Interview Populations
Group # Special Population # of 
Participants




Individuals with a Genetic Condition in the Family
1 Parents of a child with 
a genetic condition
5 Cystic Fibrosis Research Inc. 
listserv
9/03 Biological parent of a child 
with cystic fi brosis
2 Adults with a genetic 
condition
5 Providers for individuals 
with achondroplasia or 
Marfan syndrome
8/03 Individuals with 
achondroplasia or Marfan 
syndrome
Individuals with PGD Experience for Single-Gene Disorders
3 Successful PGD 3 PGD providers; Cystic 
Fibrosis Research Inc. 
listserv; Fanconi anemia 
information network
11/03 Biological mother of a child 
born after using PGD for a 
single-gene disorder
4 Unsuccessful PGD 7 PGD providers; Cystic 
Fibrosis Research Inc. 
listserv; Fanconi anemia 
information network
11/03 Woman who was unsuccessful 
in using PGD to avoid the 
birth of a child with a 
single-gene disorder (or male 
partner of)
5 Declined PGD 3 PGD providers; Cystic 
Fibrosis Research Inc. 
listserv; Fanconi anemia 
information network
11/03 Woman who considered, but 
declined using PGD to avoid 
the birth of a child with a 
single-gene disorder 
Providers
6 Nurse midwives 5 American College of Nurse 
Midwives regional listservs 
for SE and Midwest regions
7/03 Certifi ed nurse midwives 
who delivered more than 30 
babies last year
7 Obstetricians 5 Obstetrician listserv 7/03 Board certifi ed in Obstetrics 
and delivered more than 30 
babies last year
8 Family practice 
physicians
5 Family Practice Obstetrics 
listserv 
7/03 Board certifi ed in Family 
Practice and delivered more 
than 20 babies last year
9 Assisted reproductive 
technology genetic 
counselors 
5 National Society of Genetic 
Counselors ART Special 
Interest Group listserv 
7/03 Certifi ed genetic counselors 
who specialize in 
reproductive genetics and 
counsel PGD patients
10 Prenatal genetic 
counselors
5 National Society of Genetic 
Counselors listserv 
7/03 Certifi ed genetic counselors 
who specialize in prenatal 
genetics and counsel prenatal 
patients
11 PGD Nurses 4 List of 62 nurses’ e-mails 
from American Society for 
Reproductive Medicine
7/03 Nurses who provide care for 
patients using PGD for single 
gene disorders
12 PGD Specialists 
(physicians and/or 
scientists)
10 Genetics and Public Policy 
Center list of PGD specialists
7/03 Performs PGD for single gene 
disorders and/or provides 
clinical care for PGD patients
TOTAL 62
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Quantitative Research Methodology
Th e Public Awareness and Attitudes about Genetic Technology 2002 Survey (2002 survey) included telephone 
interviews with a nationally representative sample of 1,211 adults living in continental United States telephone 
households.  Th e interviews were conducted in English between October 15 and October 29, 2002.   Statistical results are 
weighted to correct known demographic discrepancies.  Details on the design, execution and analysis of the survey are 
available on the Center’s web site at www.DNApolicy.org 
Th e Study of Attitudes Towards Genetic Technologies 2004 Survey (2004 survey) collected data from 4,834 
Americans about their attitudes toward reproductive genetic technologies between April 16 and May 9, 2004. Th is 
internet-based survey, administered by Knowledge Networks (Menlo Park, CA), is the largest survey of American 
opinions on this topic to-date.  Th e respondents were randomly sampled from Knowledge Network’s web-enabled 
research panel designed to be representative of the entire U.S. population. Th e panel is representative because it 
was selected using high-quality probability sampling techniques, and it was not limited to current Web users or 
computer owners. Households were selected using random digit dialing (RDD) and each household was provided 
with free hardware and Internet access as needed for research participation.  More information about the Knowledge 
Networks methodology is located at www.knowledgenetworks.com/ganp. Research subjects for the 2004 Survey were 
U.S. residents over age 18. Blacks were oversampled. Statistical results are weighted to correct for known selection 
probabilities, demographic discrepancies, and to account for oversampling of Blacks. Th e overall survey completion 
rate of the survey was 73 percent. Th e survey instrument and research protocol were approved by the Johns Hopkins 
University Institutional Review Board.
Two types of statistical models were constructed based on survey data: ordinary least-squares (OLS) regression and 
binary logistic regression.  All data reported as “signifi cant” or “statistically signifi cant” in the text of this document met 
criteria at p<.05.  However, due to space limitations, regression models are not shown.  
Independent variables for binary logistic regression models included: age: 18-29, 30-49, 50+, female gender, 
Black ethnicity, Hispanic, religious affi  liation or not, income level: less than 25K, 25K-50K, 50K-75K, 75K+, political 
affi  liation: Republican, Democrat or other affi  liation, educational level: high school education, some college education, 
college graduate, post-graduate.     
Independent variables for OLS regression models included: age: 18-29, 30-49, 50+, urban residence, male gender, 
Black, other races, Hispanic, Protestant, Fundamentalist/Evangelical Christian, Catholic, other Christian, other religion, 
income level: 25K-50K, 50K-75K, 75K+, high school education, some college education, college graduate.
Public Engagement Methodologies
Using two diff erent 
methodologies, Th e Genetic Town 
Hall: Making Every Voice  Count 
took place in six U.S. cities using 
a town hall format, and with 15 
discussion groups online using 
state-of-the-art Internet meeting 
capability during the summer of 
2004.  In both settings, participants 
were asked to consider three 
Table 5: Chosen Children: Issues in Reproductive Genetic Testing
Chosen Children: The Science of Reproductive Genetic Testing
Chosen Children: The Ethics of Reproductive Genetic Testing
Chosen Children: The Safety and Accuracy of Reproductive Genetic Testing
Chosen Children: Impact on Families and Society
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major issues in reproductive genetic technologies: determining acceptable uses; 
examining the safety and accuracy of these tests; and considering the impact on 
individuals, families and society. Background information about the technology 
and views of a diverse group of experts were provided through educational 
videos developed by the Center entitled Chosen Children: Issues in Reproductive 
Genetic Technologies (Table 5). Th is ensured that the content delivered to each 
town hall was the same. Participants were queried at various times before, 
during and aft er the sessions to document changes in opinions as a result of 
participating in the town hall. Many of the questions were similar to the focus 
group, interview, or survey questions allowing for some comparison between 
groups.  A separate report, Th e Genetic Town Hall: Making Every Voice Count, 
which summarizes the fi ndings from this project, and copies of the Chosen 
Children videos are available at the Genetics and Public Policy Center.
In-person Town Halls
Participants for the three-and-a-half hour town halls (Table 6) were recruited 
by local coordinators using a variety of outreach strategies including placing 
notices in high traffi  c locations such as public libraries, churches, hospitals, 
clinics and supermarkets; electronic e-vites to chambers of commerce, trade 
associations, neighborhood associations and community discussion or 
roundtable groups; targeted outreach to constituencies with varied educational, 
socio-economical and racial backgrounds; and media ads and news articles.  
Th e events were advertised as free and open to the public and as an opportunity to learn more about reproductive 
genetic testing and voice opinions.  Individuals interested in participating were asked to pre-register online so that 
recruitment eff orts could be monitored. 
At the town hall, participants could choose to sit at any table. Each table of 8-10 individuals had a facilitator who was 
either invited as a local expert resource or was recruited from the pool of pre-registered participants.  Table facilitators 
were provided with a guide to facilitate the small group discussions. Participants were equipped with an electronic 
keypad to register their responses to demographic and survey questions and to rank order major areas of concern and 
optimism that were generated during the discussions.  Responses could be immediately tallied and seen by the group for 
further discussion.  
See Table 7 for the content and format of a typical town hall. At the end of the program, participants had an 
opportunity to hear from members and leader of their own communities. Th eologians and clergy, parents with fi rsthand 
experience of the technologies, medical professionals, community activist, elected offi  cials and those in the biotech 
industry gathered as local expert resources and shared their views with the audience in panel discussions. 
Demographic and survey data, as well as data ranking the list of issues identifi ed during the discussions were 
captured electronically and could be linked to individual demographic data, but not to personally identifying data.  In 
some cases, the same survey questions were asked both before and aft er the discussions to capture any shift s in opinions 
as the result of the engagement.  All six engagements were audiotaped to assist in identifying and reporting dominant 
themes and to capture representative quotes.  
Table 6: In-person Town Hall 
Schedule
Sacramento, CA
 - Tuesday, June 29, 2004
Seattle, WA
 - Thursday, July 1, 2004
Kalamazoo, MI 
- Monday, July 19, 2004
Fort Worth. TX
 - Saturday, July 31, 2004
New York City, NY 
- Monday, August 2, 2004
Nashville, TN 
- Monday, August 4, 2004
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Online Town Halls
Th e online version of the genetic town halls took place in July and August 2004.  Participants were recruited from 
Knowledge Network’s web-enabled panel. Th is panel is representative of the U.S. population because it is recruited using 
high-quality probability sampling techniques, and is not limited to current Web users or computer owners. Knowledge 
Networks selects households using random digit dialing (RDD) and provides selected households with free hardware 
and Internet access.  
9:00 a.m. Welcome 
9:10 a.m. Overview of the Process
  
9:20 a.m. Initial Impressions: eFORUM Session
  Using keypads, participants responded to questions from the moderator on their opinions and 
  values concerning reproductive genetic testing.
9:30 a.m. The Science of Reproductive Genetic Testing
  Participants viewed a video that explained the basics of reproductive genetic testing. 
9:40 a.m. The Ethics of Reproductive Genetic Testing
  Using keypads, participants responded to questions from the moderator, viewed a video on 
  the ethics of reproductive genetic testing and then engaged in a “table talk” discussion about 
  setting limits on acceptable uses of testing.  Using keypads, they rated issues to consider when 
  setting limits.
10:25 a.m. The Safety and Accuracy of Reproductive Genetic Testing
  Using keypads, participants responded to questions from the moderator, viewed a brief video on 
  safety and accuracy.  The moderator then facilitated a question and answer discussion. 
10:55 a.m.        Impact on Families and Society
  Following the video, participants engaged in a “table talk” discussion on the impact these
  technologies may have on families and society.  Using keypads, they rated their level of concern on 
  the top responses developed at each table. 
11:40 a.m.        Impressions: eFORUM Session
  Using keypads, participants responded to many of the same questions about their opinions and 
  values concerning reproductive genetic testing as asked earlier in the session. 
12:00 p.m.         Community Panel Discussion
  Regional leaders participated in a moderated panel discussion to refl ect on the themes that  
  emerged from earlier discussions.
 
12:30 p.m. Concluding Remarks
Table 7: The Genetic Town Hall  - Content and Format
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An e-mail invitation was sent to a subset of the web-enabled panel who were 18 years or older and who had a 
personal computer and home Internet connection.  Th e e-mail introduced the project and screened for technical 
qualifi cations to verify that the potential participant’s computer would work with the Lotus Sametime discussion 
soft ware.  Sametime requires an Internet connection, a multimedia-capable PC with Windows 98 or later and Internet 
Explorer 6.0 or greater.  Sametime might also not function with certain Internet fi rewalls and ‘pop-up’ blockers; 
participants who indicated that they had these features were asked if they would be willing to disable them during 
the discussion sessions.  Once agreeing to participate, participants completed an 80-item pre-intervention survey and 
selected their preferred times for the discussion groups.  A stereo headset with microphone, step-by-step user’s guide on 
how to login and use the Sametime discussion group soft ware, and two CD-ROM discs containing the Chosen Children:  
Issues in Reproductive Genetic Testing videos were sent to participants.  
Group discussions were one-hour long and scheduled for the same time each week for three weeks. A moderator who 
was also conversant in the content was assigned to moderate each group. Groups and moderators were kept intact for all 
the meetings so that the participants would be discussing topics with the same individuals throughout the project.  If a 
participant had a schedule confl ict, they were allowed to view an archived session or to move to another group for that 
week.  
Moderators followed a discussion guide that was based on the in-person town hall script. Each week one of the 
major issue area – determining acceptable uses, examining the safety and accuracy of tests, and considering the impact 
on individuals, families, and society - was the topic of discussion. Participants were told which of the Chosen Children 
videos to watch before each session and used a combination of voice chat, text messaging, and online polling to discuss 
the topic that week with their group members.  
Within a week of completing the last of the three live discussions, participants responded to a 76 item post-
intervention survey.  A randomly selected control group of 403 respondents completed identical pre- and post-survey 
instruments during the same fi eld periods as the group that participated in the engagement.  
